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ABSTRACT OF THE DISSERTATION
MACULAR PIGMENT AND LENS OPTICAL DENSITY MEASUREMENTSEVALUATING A FLICKER MACHINE WITH NOVEL FEATURES
by
Anirbaan Mukherjee
Florida International University, 2015
Miami, Florida
Professor Richard A. Bone, Major Professor
Age related macular degeneration (AMD) is one of the leading causes of
blindness amongst the elderly. Macular pigment (MP) in the retina has been
established to protect individuals against AMD. Improving levels of MP by diet
or supplements is the constant quest of clinical practitioners and researchers, thus
necessitating development of instruments capable of repeatable and reliable MP
measurement. Cataract, a consequence of the rising opacity levels of the lens with
age is one of the other major causes of blindness in the world. Mapcatsf, a LEDbased microprocessor-controlled heterochromatic flicker photometer (HFP) using
photopic vision is capable of measuring the levels of MP and the opacity of the
lens in terms of optical density.
Test-retest measurements conducted on 83 subjects were analyzed for
repeatability in macular pigment optical density (MPOD) measurements.

v

Reliability of the lens optical density (LOD) measurements were tested and
compared with those obtained at absolute scotopic thresholds for 25 individuals.
A supplement study with 32 individuals both in the young (<30) and old (>50)
age groups for 6 months further established Mapcatsf’s capacity to monitor
changing levels of MP in individuals. As an overall outcome, high levels of
repeatability and reliability were obtained in MPOD and LOD measurements
establishing Mapcatsf as an instrument for use in clinical settings in the future.
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1. Chapter 1
Macular Pigment and Eye Health
Section 1.1
What is the macular pigment?
Macular pigment(MP) is a non-bleaching yellow-color pigment that is found in
the primate retina.1 The pigment is primarily concentrated in the foveal region of
the retina2 as shown in Fig. 1.1 below. The fovea of the retina is solely dominated
by the cone photoreceptors 3 and MP is found on the Henle fiber layer of the cone
axons4 and outer segments of the rod photoreceptors.5

The Macular
Pigment

Optic Disk

Fovea

Fig.1.1 The location of the macular pigment in the macaque retina.Image
courtesy: Fig 1(a) of Malinow et al (1980).6
Entoptic phenomena such as the observation of Haidinger brushes4,7 and
Maxwell’s spot8 are explained due to the presence of MP around the fovea. The
phenomenon of Haidinger brushes can be observed as a dark shape in the form of
a “bow tie” by an individual when gazing at a uniformly illuminated surface

1

through a plane polarizer.9 The pattern rotates if the polarizer is rotated. The
rotation of the polarizer increases its visibility. The observation of the Haidinger
brushes is based on the dichroic property of the component molecules of the MP,9
the molecules whose axis lie in the plane same as the plane of polarization of the
incident light absorb the light producing the “dark” bow tie like feature as viewed
by the observer. Maxwell's spot is observed8 when we look alternately through a
yellow and a blue color filter. A dark region in the form of a circle is seen around
the area of gaze fixation when looking through the blue filter.10 The fixation of
gaze being directly mapped to the fovea centralis and MP being mostly
concentrated in the foveal region with its preferential absorption in the blue end of
the spectrum is the explanation for this effect.
Macular pigment is composed primarily of the carotenoids lutein and
zeaxanthin.11,12 The distribution of the component carotenoid molecules across the
retina was first published by Bone et al. in 1988.13 Some of the lutein is converted
into meso-zeaxanthin in the central region of the retina. Therefore, in the foveal
region, the concentration level of meso-zeaxanthin reaches maximum, and is at
negligible levels in the periphery of the retina. The distribution profile of MP
along with its component molecules are shown in Fig. 1.2 next page.

2

Fig. 1.2 The spatial distribution of the total carotenoid or the macular pigment in
the retina is shown by the purple line. The cyan line shows the ratio of lutein to
zeaxanthin. In the central retina zeaxanthin is the dominant carotenoid and the
ratio of meso-zeaxanthin to zeaxanthin is shown by the green line. Image courtesy
: Bone et al 1988.13

Section 1.2
Absorbance spectrum of the Macular Pigment
Wald in 1945 published the optical density spectrum of MP.14 Bone et al.15
applied heterochromatic flicker photometry (HFP) to 49 individuals to measure
the macular pigment optical density (MPOD), and their results agreed with that of
Wald’s published work in 1945. However a precise optical density spectrum was
published by Bone in 19929 where the density spectrum of MP, derived from its
dichroic properties, appeared almost identical to the similar spectrum obtained
from liposome-bound zeaxanthin and lutein in an environment duplicating that
associated with the MP in the retina. The normalized optical density spectrum of

3

MP is shown in Fig. 1.3. Also, data gathered by Bone in 1971 had shown that
there is a wide variability in the amount of pigment possessed by individuals,
suggesting diet, genetic, and environmental factors can be responsible for such
variability.16 Further it has been also shown that diets rich in carotenoids or
supplements containing the component carotenoids of the macular pigment can
help in improving the level or concentration of MP in an individual’s retina.17

Optical Density (O.D.)

1.2
1.0
0.8
0.6
0.4
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350

400
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Fig1.3 The normalized optical density spectrum of the macular pigment, obtained
from liposome-bound zeaxanthin and lutein as published in Bone et al in 1992. 9

Section 1.3
Macular Pigment in relation to proper eye health
The fovea is dominated by the cone photoreceptors, which are responsible for
vision under photopic or bright light conditions18 and vision demanding high
levels of acuity.18 Therefore to preserve good vision standards, maintenance of
cone health is of utmost importance.
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There are various reasons responsible for changes in the retina leading to loss of
vision, but one of the conditions that has been found to have a predominant
statistical importance, especially amongst the elderly population, is age-related
macular degeneration (AMD).19
Age related macular degeneration is associated with the loss of central vision. An
example of the appearance of the field of view to an individual with AMD is
shown in Fig.1.4.b.

Fig.1.4 (a) Sample field as seen
by a person with no vision anomaly.

Fig.1.4 (b) Sample field as seen
a person suffering from AMD.

Vision loss as a result of AMD is classified into two types viz. dry and wet.
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Degeneration in visual standards in the foveal region associated with the
accumulation of drusen or cellular debris between the retinal pigment epithelium
and the choroid is classified as dry AMD.

20

Wet AMD on the other hand is

associated with neovascularization of the aging retina, which involves formation
of blood vessels in the macular region. These newly formed blood vessels being
weak are associated with leakage leading to the loss of central vision.
Amongst the various risk factors21 for developing AMD, photooxidative22 damage
to the photoreceptors has been cited as an important one. Light of shorter
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wavelength, especially in the blue region of the spectrum, aids in transforming the
available oxygen molecules in the retina23 to reactive oxygen species such as
singlet oxygen. The subsequent interaction of these oxygen species with the
photoreceptor cells in the retina results in photooxidative damage of the
photoreceptors.24
As the MPOD spectrum in Fig.1.3 is seen to be of highest absorbance at around
460 nm and decreasing to almost zero at 550 nm, such a characteristic of the
absorbance spectrum of the MP is understood to impart it the capability of acting
in a protective capacity against excessive photooxidative damage to the
photoreceptors.25,26 The identification of this protective role of the MP against
photooxidative stress contributing to the damage to the photoreceptor cells, has
made it an important subject of research in modern days. Further, it has been
established that the higher the concentration of this pigment in an individual’s
retina, the better he/she might be protected against development of macular
degeneration.27,28 As the levels of MPOD can be elevated only by diet or by
consumption of supplements containing the component carotenoids, measurement
and monitoring levels of MPOD is essential so that individuals can be prescribed
the necessary preventive measures.
Cataract,29 along with AMD, is also a vision impairment condition, which instead
is a consequence of a heavily opaque lens and primarily treated surgically.29
However, once an individual undergoes treatment for removal of the opacity
associated with the lens, he/she is more susceptible to retinal exposure to light in
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the blue region of the spectrum. This therefore increases the chance of
photooxidative damage to the photoreceptors and the development of AMD.30
Therefore clinical practitioners, prior to removal of cataract, should consider
measuring the MPOD levels as a precautionary step and, if necessary,
recommending individuals to modify their diet or take supplements in order to
elevate protection against blue light damage by increasing the level of MP in the
patient’s retina. Hence, measurement and monitoring of MPOD of the patient
regularly is important .31
Such measurements, ideally done under clinical settings, therefore prioritize
development of repeatable, reliable, and non-invasive measurement techniques
and instruments.
Section 1.4
Methods and techniques for measuring levels of Macular Pigment
Levels of MP possessed by an individual, obtained by in vivo methods, are either
in terms of optical density27, or are in the form of signal counts available from
resonance Raman spectroscopy.32 Over the years researchers have developed
various techniques for measuring macular pigment optical densities (MPOD)
which are either signal-based such as the autofluorescence33 and reflectance34
measurement techniques, or are psychophysical in nature such as heterochromatic
flicker photometry (HFP)35,36 and heterochromatic brightness matching (HBM).37
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The signal-based autofluorescence and the reflectance method, aside from being
expensive, suffer from loss of signal in the aging eye. In the case of
autofluorescence, such loss is the result of scattering of light38 by the aging lens
and for reflectance measurements, losses in signal are caused by the presence of
drusen in the back of the retina.38,39
Signal loss is not a considerable factor in psychophysical methods. The
psychophysical methods also involve minimal risk, are subject-friendly and
instrumentation is relatively easy to fabricate. On the basis of the factors
mentioned, the psychophysical techniques have become the preferred choice of
MPOD measurement amongst researchers and clinical practitioners. Between
HBM and HFP, HFP has emerged as the more popular choice of psychophysical
methods of measurement. The reason for HFP to become the preferred choice has
been the strong similarity of the MPOD spectrum measured in vivo by HFP to
that measured under in vitro conditions.35,15
Though researchers have pursued refinements of HFP,40,41,42,35at the heart of HFP
measurement is the concept of achieving a luminance match between two light
sources made to flicker in anti-phase to each other32. Through instrumentation
techniques, the frequency of flicker can be controlled by adjusting the angular
frequency of a rotating chopper as described in Bone and Landrum32 or
electronically as described in Bone and Mukherjee.43 To facilitate measurement,
one of the component light sources of the stimulus has a peak wavelength close to
the peak absorbance of the MP and the other with a peak at a region of the

8

spectrum where the absorbance of MP is almost zero.44 Such sources can be
derived from the light emitted by a single Halogen lamp and passing the light
through interference filters to obtain the desired wavelengths,35 or from
independent LED sources43. Heterochromatic Flicker Photometers that derive
light solely from LED sources are termed as LED-based machines. The
perception of flicker is minimized by either the operator or the subject, adjusting
the intensity of the light in the blue channel either by translating a variable density
wedge

35

for halogen-based instruments or by adjusting the settings of a

logarithmic potentiometer40 in LED-based instruments.
As the MP is primarily concentrated in the fovea, with its distribution becoming
almost negligible beyond 5º eccentricity in the retina,45 HFP measurement is
divided into two phases, foveal and perifoveal. Testing for the foveal phase
involves achieving a minimum flicker or no flicker for a stimulus that is entirely
imaged on the fovea of the retina. Such a stimulus is generally of the order of 1 to
1.5 degrees in diameter.35 As a result of the spatial distribution profile of the MP,
the elimination or minimization of flicker for the entire stimulus is affected by the
presence of MP along with other pre-receptoral filters, chiefly the lens in the
eye.46,47
For the foveal measurements, the subject is directed to keep his/her gaze fixed at
the center of the presented stimulus and to adjust a handheld control to achieve a
flicker null. For subjects who find difficult the simultaneous operation of the
control and keeping their gaze fixated, there is the provision in some instruments
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for the operator to adjust the settings.39 Such a provision necessitates the subject
to communicate to the operator verbally whether a flicker null is achieved or not.
For statistical purposes, the flicker null/minimum settings are recorded a
minimum of three times, but more usually, five times.
On completion of the foveal phase, the perifoveal phase of the testing procedure is
conducted. For the perifoveal flicker null testing, some instruments require the
subject to fixate their gaze at a different location in the field of view and minimize
the flicker for the previously used foveal stimulus, which at this time appears to
be imaged in the perifoveal region of the retina. However some instruments have
an alternative approach to the above mentioned procedure. The alternative
approach associated with perifoveal testing is minimizing or adjusting for a
flicker null condition in the periphery of a larger centrally viewed stimulus either
in the form of a full circle as used in the instrument described by Bone et al.43or
an annulus as described in Wooten et al.41 which replaces the previously tested
smaller stimulus. The large stimulus replacing the smaller stimulus is typically of
the order of 15º diameter in size. Regardless of the type of stimulus used, the
flicker null settings reported can be attributed to the presence of pre-receptoral
filters aside from MP, primarily the lens.43 Similar to the foveal measurements,
the measurements are repeated at least three times. The difference between the
intensity settings for the foveal and the perifoveal flicker null settings can hence
be considered to be a direct consequence of the presence of MP. Therefore,
applying the necessary mathematical calculations and taking into account various
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spectral templates, we can compute the luminance associated with the individual
light sources at the flicker null/minimum settings and calculate the MPOD.
Though significant refinements have been achieved over the years in MPOD
measurement by HFP, there are still two drawbacks that have not yet been
eliminated. One such drawback is Troxler fading of a peripherally viewed small
stimulus.43 The other occurs if the subject, during the perifoveal testing,
inadvertently looks directly at the flickering stimulus instead of the eccentric
fixation mark while reporting the flicker null condition. In such cases, he/she
would merely be repeating the foveal phase of the testing procedure.43
The Mapcatsf instrument addresses the two above mentioned difficulties
encountered in other HFP instruments. In the present dissertation we evaluate the
suitability of using Mapcatsf, a LED-based, fully microprocessor-controlled HFP
instrument whose primary features are to measure MPOD and the lens density in
terms of lens equivalent age, by clinical practitioners and researchers.
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2. Chapter 2
Instrument Design and Subject Testing Procedure

Section 2.1
Instrument design
The MPOD measurement by HFP is a two-step process and the reason for the
limits or size of the stimulus used in each of the separate steps is explained
referring to Fig. 2.1 below.
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Fig 2.1 The luminous efficiency functions plotted for centrally viewed fields of 10
degree (dashed line) and 2 degree (solid line) in diameter.

In Fig. 2.1, the difference in the photopic luminous efficiency functions for 2° and
10° stimuli is seen in the short wavelength region. Such a difference is attributed
to the concentration of MP primarily in and around the foveal region. Therefore
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for the foveal phase of the flicker null testing in most of the instruments, a small
centrally viewed stimulus of around 1 to 2 degree diameter is used. Such a
stimulus when imaged on the retina falls directly on the fovea. The stimulus used
in Mapcatsf for foveal testing is 1.5º in diameter and is associated with a
vertical/horizontal cross hair for central gaze fixation. Gaze fixation is associated
with eye movements,48,49 which are termed as fixational eye movements, a topic
discussed in detail in Chapter 9. The mean amplitude associated with such eye
movements is of the order of 0.36º.50 Therefore the area of retina sampled during
MPOD measurement could be larger than the stimulus area depending on the size
of these eye movements. To minimize this effect, the size of the foveal stimulus
was chosen to be of 1.5º diameter rather than 1° as in a number of other
instruments.
For the perifoveal testing on Mapcatsf, a large centrally viewed 15º diameter
circular stimulus associated with vertical/horizontal cross hairs for gaze fixation is
used. As the concentration of MP reduces to negligible levels at about 545 to 751
degrees eccentricity in the retina, the 10 degree luminous efficiency function is
applicable for the 15º diameter stimulus without any significant differences being
associated. The flicker null reported in the periphery of such a large stimulus can
be considered to have no association with the absorbance of MP,45 but rather to be
primarily affected by the optical density of the lens.43
The schematic optical setup of Mapcat is shown in Fig. 2.2. The LED light
sources used to generate the stimuli are a 3W blue LED of peak wavelength at
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455 nm and half bandwidth 20 nm and a 1W green LED of peak wavelength at
515 nm and half bandwidth of 33 nm.43 The LED sources associated with heat
sinks are mounted in the integrating sphere S1, so that the resultant light obtained
is spatially uniform.

Fig 2.2 The optical setup of Mapcatsf. The interior of the sphere S1 is illuminated
by the blue and green LEDs. The intensity settings of the blue and green LEDs at
flicker null are measured by the photodioide PD. The apertures on disk D provide
the 1.5 º and 15º stimuli as viewed by the telescopic setup which consists of the
lenses L1 acting as the objective and L2 acting as the eyepiece along with the field
stop F and aperture A. The front surface of D is illuminated by the LEDs on the
sphere S2. Image courtesy from SPIE, JBO43
It is known that current-controlled LED outputs result in a shift of their peak
wavelength with current.43 To avoid such a change in the LED spectrum, the
outputs were frequency controlled. Such a control mechanism was obtained by
applying frequency-modulated fixed amplitude pulses to the LEDs. Bi-stable
electronic circuits were used to obtain the “on” and “off” cycles, so as to enable
the output of the blue and the green LEDs to be in antiphase to each other at
frequencies between 10 and 40 Hz43 resulting in the visual perception of flicker. A
logarithmic potentiometer, in the form of a handheld control device, is used to
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adjust the intensity of the blue LED source by the subject to report a flicker null
condition while centrally viewing the testing stimulus.
A flicker null condition is achieved when the photoreceptors in the subject’s
retina perceive matching luminance levels between the light in the blue channel
and light in the green channel. A photodetector positioned on the sphere S1 as
shown, samples the light from the inner rear surface of the sphere at the flicker
null condition. The microprocessor associated with the photodetector is
programmed to gather the intensities recorded by a sample-and-hold technique.
Such a technique gathers many samples of the intensities of the light from both
the blue and the green LEDs. For computational purposes; the averages of the
results are taken and are represented by the symbol φ , with pertinent subscripts
for the blue and the green LEDs respectively, shown in Eq.s (1) - (3) in section
2.2.
The emergent, spatially uniform light from sphere S1 is designed to pass through
additional apertures provided on an opaque disk “D” which, along with the
telescopic setup consisting of the lenses L1 and L2, aid in setting the desired
dimensions of 1.5º and 15º diameter for the circular stimuli used during the foveal
and the perifoveal testing phases. Further, the field stop “F” limits the total field
size at 24 degrees.43 The disk D is rotated to switch stimuli between the two
phases of testing by a rotary solenoid. To facilitate gaze fixation, both the stimuli
used are provided with cross hairs.
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Just anterior to the disk D, a second sphere labeled as S2, is located, fabricated out
of two hemispherical surfaces. Two 1W green LEDs of the same peak wavelength
and bandwidth as the ones in sphere S1 are mounted on S2. These LEDs are also
provided with heat sinks and are used to illuminate the front surface of the disk D
in order to create the necessary photopic viewing conditions. To facilitate the
condition of uniform luminance at flicker null settings across both the field and
the stimulus, the luminance of the green LEDs in the sphere S2 is set to match the
luminance of the green component of the stimulus. The interior surface of the
hemisphere closest to the disk D is painted white and that of the other hemisphere
is painted black, both with a matte finish. The matte black finish prevents
feedback of any scattered light generated in S2 to the reflecting surface of the
sphere S1.
Aside from the lens L2 and the viewing aperture “A”, the rest of the setup is
mounted on a translational slide controlled by a stepper motor. Such a mechanism
is provided so that distinct focusing of the cross hair stimulus on the disk “D” is
facilitated according to the participating subject’s visual accommodation level. As
maintaining the angular size of the stimuli during the testing phases is very
crucial, the lens L2 is positioned at a distance from the viewing aperture A such
that the distance between the eyepiece lens L2 and the nodal point of the subject’s
eye is equal to the focal length of L2. The particular alignment of the lens L2
described results in a constant angular size of the retinal image, regardless of the
subject's state of accommodation.
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Fig. 2.3 The ray diagram explains the fact that when the distance between the
nodal point of the eye and the eyepiece lens L2 is equal to the focal length of L2,
the angle subtended by the stimulus imaged on the retina is the same regardless of
the position of the second image I2, which is adjusted based on the subject’s
accommodation.
In Fig. 2.3, F1, F2 are the focal points of the objective and the eyepiece lenses L1,
L2 respectively, with “N” being the nodal point of the eye. “O” depicts the
extremity of the stimulus used, with I1 and I2 being the images formed by the
lenses L1 and L2. Since I2 is a virtual image, it is represented by a dashed line in
the Fig.. The angle “ α ” depicts the angular size of the image of I2 formed on the
retina. Applying trigonometry we get:

tan α =

hI1
F2

17

..........(1)

In Eq. 1 above hI1 is the height of the image I1 and F2 is the focal length of the
lens L2. By applying the lens Eq. to the lens L1, the radii of the original apertures
on disk “D” can be fabricated for the 1.5º and 15º stimuli for foveal and perifoveal
testing respectively.
Since Mapcatsf does not employ a dental bite, lack of precise eye positioning
could result in small variations in the distance between the nodal point of the eye
and the eyepiece lens, but errors introduced thereby due to the unaligned eye
positioning can be ignored.43
Section 2.2.1
Theory for MPOD measurement
The photodetector in the sphere S1 is used to detect the intensity of the green
LED, which is steady, and the adjusted intensity of the blue LED at the flicker
null condition. The photodetector outputs recorded for the blue and the green
LEDs at the settings of foveal and perifoveal flicker null can be expressed
mathematically as shown below:

φBF = k F  I B ( λ )S ( λ ) d λ ……...................................(2)

φBP = k P  I B ( λ )S ( λ ) d λ ………….............…...……(3)

φG =  IG ( λ )S ( λ ) d λ ………....................................…(4)
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The terms I B , I G are the normalized intensity spectra of the blue and the green
LEDs. The multipliers k F , k P are the factors that arise due to adjustment of the
luminance levels of the blue LED by the subject to arrive at the flicker
null/minimum conditions during the foveal and the perifoveal phases of testing
respectively. The term S ( λ ) is the sensitivity spectrum of the photodetector
mounted in the sphere S1. From Eq.s (2) and (3)

k F φBF
=
………………………(5)
k P φBP
The achievement of the flicker null during the foveal or the perifoveal phase is the
result of matching of luminance levels between the light from the component
sources at the foveal region of the retina during the foveal phase or at the
periphery during the perifoveal phase. The luminance match conditions for the
foveal and the perifoveal flicker null/minima conditions are expressed
mathematically as shown in Eqs. (6) and (7) respectively.
k F  I B ( λ )10− PD( λ ) V ( λ , a ) d λ =  I G ( λ )10 − PD( λ ) V ( λ , a ) d λ ...............(6)

k P  I B ( λ )V ( λ , a ) d λ =  I G ( λ ) V ( λ , a ) d λ ………….................…(7)
In both the Eq.s, the term V ( λ , a ) is the age-modified luminous efficiency
function of the human eye, obtained for a centrally viewed stimulus of 10º
diameter. Though a standard 2º luminous efficiency function is available, the 10º
function was used in the Eqs. so that the transmittance of MP could be observed
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as a separate parameter and the subject’s peak MPOD can be computed from it.
As the MPOD is considered to be almost negligible beyond 5 to 7 degrees
eccentricity,51 the 15º diameter stimulus was used for perifoveal testing. The term

D ( λ ) is the macular pigment optical density spectrum,9 normalized to unity at
the peak optical density and P is the peak MPOD of the subject being tested43.
Taking into account the spatial distribution profile of MP, the term representing
the transmittance of MP is absent in Eq. (7). Division of Eq. (6) by Eq. (7), and
taking into account the results from Eq. (5), leads to
− PD ( λ )
V ( λ , a ) d λ  I B ( λ )V ( λ , a ) d λ
φBF  IG ( λ )10
….............................. (8)
=
×
φBP  I B ( λ )10− PD( λ ) V ( λ , a ) d λ  I G ( λ ) V ( λ , a ) d λ

If instead of LED sources, monochromatic light sources were used, Eq. (8) above
reduces to

φ 
P = log  BF  …………..................…...........…………. (9)
 φBP 
Such an expression, however, is only valid if the density spectrum of MP D ( λ )
has its maximum at the wavelength of the blue source and is zero at the
wavelength of the green source.
On inspection of Eq. (8), if the spectral characteristics of the LED sources are
known along with V ( λ , a ) (the 10º luminous efficiency function for a certain
age), then we can numerically solve Eq. (8) to obtain a relation between P and the
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ratio of the photodetector outputs of the blue light intensities recorded at the
foveal and the perifoveal flicker null conditions,

φBF
.
φBP

Sagawa and Takahashi 52published a template as shown below in eq. (10) which
describes the variation in the luminous efficiency function with age. The reference
age has been changed from the original 64.9 years to 32 years since the CIE 1951
approved V10 ( λ ) was the fitted data for a group of subjects whose average age
was 32 years.

log V ( λ , a ) = log V ( λ ,32 ) + (a − 32)α ( λ ) ……….................(10)52
The parameter α λ is the change per year of the log luminous efficiency, attributed
to the aging lens by Sagawa and Takahashi. Hence the parameter “ a ” associated
with V ( λ ) can be termed as the "lens equivalent age" or LEA.

φ 
In Fig. 2.4 the plot of “P” versus log  BF  is shown for various values of LEA.
 φBP 
The LEA is computed from the perifoveal flicker null settings which we explain
in the following section. Once the LEA is obtained, the MPOD±SEM (standard
error in the mean) is computed by the microprocessor essentially by selecting the
pertinent curve from Fig. 2.4.
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Fig. 2.4 The plots of P vs log  BF  for LEAs at 5 years intervals between 20 and
 φBP 
90 years.

Aside from computing the MPOD along with the associated standard error in the
mean, the microprocessor computes the average percentage of the light blocked in
the blue end of the spectrum (400 to 500 nm) by computing the mean of the
expression ( 1 − 10 − PD ( λ ) ). The capacity of Mapcatsf to compute the percentage of
the light being blocked in the blue region of the visible spectrum is a more readily
understood quantity for the layperson who is likely to be unfamiliar with the
concept of optical density.
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Section 2.2.2
Theory of LOD or LEA measurement
At large retinal eccentricities, the presence of MP can be ignored. Taking into
account the optical density spectrum of the lens, the perifoveal flicker null
condition that result from match of luminances between light from the component
blue and the green sources of the 15º stimulus can be considered to be affected by
the age-related changing levels of the density of the lens. The ratio of the
photodetector outputs of the intensities of the blue and the green LEDs can be
combined with luminance of the light sources at the perifoveal flicker null
condition according to eq. (11) below.
φBP  I G ( λ ) V ( λ , a ) d λ  I B ( λ ) S ( λ ) d λ
=
×
φG  I B ( λ ) V ( λ , a ) d λ  IG ( λ ) S ( λ ) d λ

............................(11)

If the spectral characteristics of the concerned variables in the right-hand side of
eq. (11) are known, then the left hand side, or the ratio of the photodetector
outputs, can be seen to be only dependent on “ a ”. As the variable “ a ” in Eq.
(11) has been referred to as LEA earlier, in Fig. 2.5 we show the variation of LEA
with

φBP
.A curvefit polynomial programmed in the microprocessor computes the
φG

LEA along with the associated standard error in the mean.
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Fig. 2.5 The polynomial fit used to obtained the lens equivalent age or LEA from
the intensity ratios of the blue and the green LED sources detected by the
photodetector at perifoveal flicker null settings, φBP .
φG

Section 2.2.3
LEA computation based on templates derived from excised lenses.
Sagawa and Takahashi attributed the changes in the photopic luminous efficiency
function in the shorter wavelengths to the age-related changes in the optical
density of the lens. This prompted us to test templates developed from data from
excised lenses, such as the ones by Pokorny et al.

46

and van de Kraats and van

Norren.47 To develop the luminous efficiency function, a 10-degree luminous
efficiency function was obtained for an aphakic individual. To develop the
luminous efficiency function for an aphakic individual the standard V10 ( λ ) was
divided by the transmittance of the lens for a 32 year old individual obtained from
van de Kraat’s age-related lens density template. The resulting function was
subsequently multiplied by the age-dependent lens transmittance spectrum of the
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model being tested. The resultant V10 ( λ ) was included in Eq. (10) to numerically
solve for the ratio of the photodetector outputs

φBP
as a function of the lens
φG

equivalent age (LEA) labeled as “ a ”. The graphical representation of the
variation of

φBP
with LEA for the two templates tested, aside from the one by
φG

Sagawa and Takahashi, is shown in Fig. 2.6.

φ BP
φG

Fig. 2.6 The plots of

φ BP
φG

with LEA, using the three different templates.

The solid green line is obtained by using the template suggested by Sagawa and
Takahashi. The red and blue dashed lines are obtained as a result of using
templates suggested by Pokorny and van de Kraats respectively.

In Fig. 2.6 we observe that there are large discrepancies in the LEA measurements
when comparing the ratio of the photodetector readings obtained using the three
separate templates. We compare the results of the two templates taking the results
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derived from Sagawa and Takahashi as a standard. If, for example, an individual
had an LEA of 40 years when using the Sagawa and Takahashi template, he/she
would have an LEA of 34 if the Pokorny template was used and would not be
traceable to any LEA if the van de Kraats template was used. Similarly if
someone has an LEA of 60 years according to the Sagawa and Takahashi
template, he /she would have an LEA of 41 years according to van de Kraat’s
template but would report an LEA of 68 years according to the Pokorny template.
In chapter 3 we explain in detail why we programmed the Mapcatsf using the
template by Sagawa and Takahashi.
Section 2.3
Subject testing procedure:
The testing on Mapcatsf enables testing one eye at a time. The instrument is
placed on a hydraulic adjustable table with the subject seated on an adjustable
chair to facilitate proper height adjustments. An adjustable chin rest is also
provided to have the subject’s head partially fixed. The non-testing eye is
occluded by an eye patch. The occlusion of the non-testing eye was initiated on
the basis of subjects’ feedback, that if the non-testing eye was available for vision,
it actually made gaze fixation difficult for the testing eye. Prior to the
commencement of the testing, the entire test field consisting of the 1.5º (foveal)
central gaze fixating stimulus is focused based on the subject’s accommodation
level. During the focusing phase, the blue component and flicker are turned off
leaving both the stimulus and the surrounding field uniform green. The handheld
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control device operates an optical encoder that provides movement of the
translational stage via a stepper motor enabling back and forth movement of the
optical layout aside from the eyepiece lens L2 and the viewing aperture “A”. Such
a mechanism enables adjustment of the stimulus derived from the cross hair
reticle on disk “D” so that it is focused on the retina according to subject’s
accommodation.
Once proper focusing has been ensured, the blue LED and the flicker are turned
on by the operator. By default, the frequency is set to 24 Hz by the operator. At
this stage, turning the knob controls the intensity of the blue LED, behaving as a
logarithmic potentiometer. The operator guides the subject to turn the knob fully
clockwise and then counter-clockwise to impart the idea of the change of the
apparent flicker with the variation of intensity of the blue component of the
stimulus. Once the subject gets accustomed to the operation involved in the
testing, the subject is asked to fix his/her gaze at the center of the stimulus and
operate the knob until a flicker null or minimum is visually perceived for the
entire stimulus.
Further, the subject is also instructed that at the flicker null/minimum condition,
the luminance of the surrounding green region will appear the same as that of the
stimulus. The testing for the 1.5º stimulus is called the foveal phase of the testing
procedure since the entire stimulus is imaged on the foveal region of the retina.
Once the setting for minimum or null flicker is achieved, the intensity of the blue
light is recorded by the microprocessor and a subsequent offset is introduced in
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the intensity of the blue component of the stimulus. The process can be repeated a
total of 10 times but is generally executed between 4 and 5 times. If a subject
reports a wide range of knob settings for perception of flicker minimum, the
frequency is reduced from 24 Hz and on the contrary if it gets hard to obtain a
well-defined flicker minimum, the frequency is increased from 24 Hz. The
adjustment of the frequency based on the subject’s performance is called
“customized heterochromatic flicker photometry" or cHFP, first reported by
Stringham et al.53
On completion of the foveal phase, the 15º diameter stimulus replaces the 1.5º
diameter stimulus and the flicker frequency is set at 31 Hz by default. For this
phase of testing, the subject is directed to operate the handheld control and
eliminate the flicker from the peripheral part of the stimulus while keeping his/her
gaze fixed at the center of the cross hairs. Under such conditions, the subject
observes a central flickering zone along with the flicker null zone in the periphery
as shown in Fig. 2.7 below.
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No flicker
Central Flicker

Fig 2.7 The appearance of the 15º stimulus to the subject when the flicker
null/minimum condition is reported in the periphery.

Further, it is communicated to the participating subject that the area of flicker
null/minimum should be as large as possible leaving a central circular region of
flicker around ~ 5 to 8 degree diameter.43 The flicker null condition is sharply
defined when tiny offsets to the knob position from the flicker null settings result
in emergence of flicker for the entire stimulus. As with the foveal phase, the
measurements can be recorded 10 times but are generally limited to 4 or 5 times.
The small flickering region surrounds the fixation point and is due to MP.
Therefore maintenance of precise fixation is not necessary and, from experience,
it has been observed that the phenomenon of Troxler fading is absent. Further,
compared to another instrument, the Maculometer,54 the problem for some
subjects of inadvertently gazing directly at a small perifoveal flickering stimulus
is removed. The inadvertent shift in gaze to the perifoveal location is a prime
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concern since if the flicker null/minimum conditions are recorded when the
subject is gazing directly at the intended perifoveal area, he/she is basically
repeating the foveal phase of the testing since MP is mostly concentrated in the
fovea.
On completion of the perifoveal measurements, the microprocessor computes the
MPOD. Lens optical densities (LOD) are calculated from the perifoveal
measurements. However the LOD is computed at 425 nm taking into account the
age-related variation of luminous efficiency, as published by Sagawa and
Takahashi.52 A tablet display attached to the outer cabinet of the instrument
displays the MPOD, the LOD, and the lens equivalent age (LEA), along with the
associated standard errors in the means of each of the computed quantities. As an
additional and novel feature, the average percentage of blue light blocked by MP
is also displayed along with the average intensities of the blue light detected at the
foveal and perifoveal flicker null/minimum. The instrument, if interfaced by a
USB cable, has the capacity to provide a printout of the results. A sample of a
printed result is shown in Fig. 2.8 below.
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Fig 2.8 A printed sample of the test results.
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3. Chapter 3
Pathway to Establishing Credibility of Mapcatsf
Section 3.1
Test Retest Results
In order to establish the repeatability of measurements, we performed a test-retest
analysis. Eighty three naïve subjects were recruited for this purpose. The subjects
were all aged between 19 and 79 years (mean ± SD = 36 ± 17 years). Out of the
83 subjects, 4 had undergone cataract surgery. One had been diagnosed with dry
AMD but still possessed a 20/20 level of visual acuity. The subjects, prior to
being tested, signed an informed consent approved by the IRB at Florida
International University. The study conformed to the tenets of the Declaration of
Helsinki. The operator described every step of both the phases of testing to the
subject using a Power-Point presentation. A minimum of 4 times, the flicker null
was tested for both the foveal 1.5-deg stimulus and the perifoveal 15-deg
stimulus. Both MP and the lens densities maintain almost the same level in both
the eyes, therefore only the right eye was tested.55,56 When questioned, the
subjects responded that arriving at the flicker null settings for the 15-degree large
stimulus was much easier than for the 1.5-deg stimulus, with Troxler fading not
being an issue during the perifoveal phase of test. Such responses are supported
by the average standard deviations for the foveal and the perifoveal flicker null
settings which were 0.0263 and 0.0124 (arbitrary intensity units) respectively.
The retest was conducted on the same day following the completion of the test.
To analyze repeatability, we conducted a Bland Altman analysis for the 83
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subjects by plotting the difference in the test-retest MPOD measurements with
respect to the mean of the test-retest measurement. The plot is shown in Fig 3.1.

Difference between test and retest
in MPOD measurements
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Mean value of MPOD from test and retest

Fig. 3.1 Graph showing the Bland Altman analysis for the 83 subjects where the
difference in MPODs measured during the test and retest is plotted with respect to
the mean of the MPODs measured. The solid line depicts the mean of the testretest and the dashed horizontal lines are the limits of agreement.
On analysis of Fig 3.1, the average difference between the test retest of MPOD
was 0.004 density units with the limits of agreement (mean ± 2 SD) being 0.004
± 0.075 density units.
Results from retest of MPOD measurements were plotted with respect to the
values of MPOD measured during the testing phase as shown in Fig 3.2 below.
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Fig 3.2 The scatter plot along with the regression analysis for MPODs measured
during retest with respect to the MPODs measured during test for 83 subjects.

A regression analysis of Fig 3.2 was conducted which resulted in the R2 value of
0.9554 and p-value < 0.0001. The Eq. of the associated regression line was
y=0.9859x+2.11x10 -3.
As mentioned in section 2.2.2, the associated microprocessor program with
Mapcatsf uses the modified age-related luminous efficiency function suggested by
Sagawa and Takahashi to compute the lens optical density and lens equivalent age
which in turn is further utilized to compute the MPOD values. To test the validity
of the programmed model, we plotted the LEA obtained from Mapcatsf with the
actual age of the subject as shown in Fig. 3.3 below.
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Fig. 3.3 The LEA or lens equivalent age is plotted as a function of the subject’s
actual age. The solid line is a line of slope unity. The points above the line are the
ones for the subjects whose LEAs were more than their actual age and the points
that are below are the ones for whom the LEAs were less than their actual age.
From regression analysis of the scatter plot in Fig. 3.3 the R2 value was 0.775.
The Eq. of the regression line for the plot in Fig.3.3 was of the form
y=0.807x+6.701.The level of agreement between the LEA and the actual age of
the subjects was interpreted from the slope of the regression line which was
0.807. The high values of both the R2 and the slope of the regression line for the
scatter plot in Fig. 3.3 indeed support Sagawa and Takahashi’s explanation for the
change in V10 ( λ ) with age being mainly because of the changes in the optical
density of the lens. In Fig. 2.6, we had observed high levels of discrepancy that
arise using templates from excised lenses when compared to results from Sagawa
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and Takahashi. Since the regression analysis of Fig. 3.3 yielding high levels of
agreement between LEA and actual age, using the age-dependent template
developed by Sagawa and Takahashi would be the appropriate choice for LEA
and MPOD measurement.
Section 3.2
Testing of Mapcatsf beyond test-retest to determine its reliability
The preliminary test-retest results with Mapcatsf have shown high levels of
repeatability with a mean of the difference between test and retest of only 0.004.
The value of the difference implies that if an individual is tested over and over
again, the value of MPOD would not vary significantly considering that other
factors remain the same.

However repeatability of measurements does not

guarantee reliability in measurements obtained by an instrument. Results from
further testing are presented in the following chapters to establish the reliability
on the data obtained by Mapcatsf.
Because Mapcatsf is a LED-based HFP machine, either of the component LED
sources might need to be replaced. From our experience, commercial LEDs
purchased vary in spectrum as far as their peak wavelength is concerned by at
least a few nanometers from their prescribed nominal values on their package.
Ideally an instrument should not exhibit high levels of variation in measurement
associated with minor variations in the spectra of the components. We
investigated the effects, if any, of changing the component LEDs' peak
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wavelengths on the measured values of MPODs or LODs. The procedure was to
simulate a shift in the spectra of both the component LEDs and then compare the
outcomes with the results obtained for the LED pairs for which the
microprocessor was originally programmed. The simulations and the details of the
analysis are given in Chapter 4.
Researchers have reported age-related changes, especially a decline with
age,57,58,59 in MPOD measured using instruments that employ the HFP technique
but do not account for the changing levels with age of the luminous efficiency
functions of the participating subjects. Change in the luminous efficiency in the
short wavelength region of the spectrum with age, as attributed by Sagawa and
Takahashi,52 is considered to be an artifact of the aging lens. Age-related change
in the density of the lens is termed as lens-yellowing,46 which means the lens
essentially absorbs more light in blue end of the spectrum for older lenses
compared to the young transparent lenses. Elevation of the optical density with
age will therefore contribute in higher luminance levels in the blue channel
required for reporting a flicker null/minimum condition during the perifoveal test
phase of measurement. We believe the result of the luminance of the blue light
being high during perifoveal testing is a contributing factor to the apparent decline
of the values of the MPODs in aging subjects. Therefore to confirm our
hypothesis we ran simulations to check if an apparent age-related decline in
MPOD is observed if the changing luminous efficiency with age is not accounted
for. Details of the simulation with the analysis and results are given in Chapter 5.
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The feature of obtaining the lens density LOD, interpreted in terms of lens
equivalent age or LEA, is an ancillary feature of Mapcatsf.

The viewing

conditions being photopic during testing by Mapcatsf, vision is mediated by the
cone photoreceptors, chiefly by the L (long) and M (medium) wavelength
sensitive cones. However the ratio of the L-cones to M-cones, interpreted in terms
of weight, is known to have a wide range of variation in value across
individuals.60,61 Such variation in weights is believed to affect lens density
measurements under photopic viewing conditions. On the other hand, vision
under scotopic or minimum light conditions, is rod-mediated and is associated
with the rhodopsin absorbance spectrum which is known to not vary significantly
across individuals. Lens densities measured under scotopic conditions, especially
at absolute thresholds, are therefore considered to be more precise in value56,62
Hence an experiment was conducted to compare lens densities of subjects
measured in terms of LEA under scotopic vision at absolute threshold with those
measured by Mapcatsf. Details of the experiment and outcomes are described in
chapter 6.
In chapter 7 we report the capability of Mapcatsf for monitoring changing levels
of MPOD. Previously in section 1.3, we have mentioned that higher levels of
MPOD can lower the risk of an individual developing AMD. Studies have shown
that increase in levels of concentration of MP in individuals has been possible
through diet63 or supplements17 rich in the component carotenoids making up the
macular pigment. Also increased levels of MPOD resulting from supplementation
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do not change significantly over time.17 Clinical practitioners along with
researchers are always interested in testing new effective supplements which can
enhance the concentration levels of MP in the human retina. Macular pigment
optical density(MPOD) being proportional to the concentration of the pigment,
and HFP being one of the preferred choices of measurement, Mapcatsf’s capacity
to measure changing levels of MPOD in an individual’s eye was tested. Thirty
three human subjects with no previously known vision problems were put on
either lutein or ester derivatives of lutein, zeaxanthin and meso-zeaxanthin for six
months and their MPOD levels were monitored regularly at 8 weeks interval over
the supplementation period.
Carotenoids, especially lutein, have been found in traces in the ocular lens.64 Diets
rich in carotenoids are known to reduce the chances of individuals developing a
cataract. Near-UV and blue light exposure has been established to be one of the
chief factors for an individual to develop senile a cataract.65 Taking into account
the absorption spectrum of lutein, which peaks in and around 460 nm, this
carotenoid can be considered to act as a blue light filter. While it is sufficiently
concentrated in the retina to potentially limit blue light damage, its concentration
in the lens is too low for similar action in this organ. On the other hand, its antioxidant potential in the lens may be relevant in reducing damage to the lens and
therefore reducing the risk of developing cataract. However the exact mechanism
of how, or even whether, the presence of the carotenoids helps maintain an
optically transparent lens is still subject for research.64The lens derives its
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nutrients indirectly from the bloodstream, and there has been a proven
relationship between levels of MP in the retina and the carotenoid level in the
blood serum. Therefore analyses were conducted to see if higher levels of
MPOD are associated with a more transparent lens due to the protective nature of
the traces of lutein found on the lens.64 The details of the study and analytical
outcomes are provided in chapter 8.
It has been debated whether MPOD measured by HFP represents the value at the
edge of the image of the foveal stimulus instead of an average of the entire image
area.66,

67

Bone et al. in 2004 argued against this hypothesis, attributing MPOD

values that were less than the average to involuntary eye movements associated
with gaze.48 In chapter 9 we present the results of an experiment that we
conducted to infer if a central gaze fixating foveal stimulus can be designed which
would minimize the effects of such fixational eye movements.
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4. Chapter 4
Effects of Shifts in Spectrum of the Component LEDs

Section 4.1
Introduction
Mapcatsf, discussed in Chapter 1, uses high power LEDs as the sources of light.
The component LED sources might need to be replaced. However, commercial
LEDs are available with labeled nominal values of their peak wavelengths and
bandwidths, which are observed to have variability when their spectra are
analyzed using a spectrophotometer.
In section 2.2, Eq.s necessary to compute the MPOD and LOD or LEA on
Mapcatsf directly involve the spectral characteristics of the component LED
sources. Therefore, investigation of the effects on the MPOD and LOD
measurements because of variations in the matching levels of the luminance
caused by shifts in peak wavelengths of the component LEDs of the stimulus, is
of prime importance.
Section 4.2
Theory
The operation of the Mapcatsf for arriving at the flicker null involves adjusting
the luminance of the blue LED light source while having the luminance of the
green LED light source fixed. The LED sources are broad bandwidth sources. The
relationship between the peak macular pigment optical density “P” and the ratio
of the photodetector readings of the blue light at the foveal and perifoveal flicker
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null conditions is obtained from the polynomial fit, unique for an individual’s
LEA, as shown in Fig.2.4. The polynomials in Fig.2.4 are cubic in nature and are
of the form as shown in Eq.1 below:
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As discussed in detail in section 2.2.2, the LEA is obtained from the luminance
match conditions during the perifoveal flicker null conditions in accordance with
the polynomial fit to Fig. 2.5, which is of the form as shown in Eq. 2 below:
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The critical role played by the luminance match between the component LEDs is
further established from the fact that values of the MPOD and the LEA measured
by Mapcatsf are based on Eq.8 in section 2.2.1 and Eq.11 in section 2.2.2
respectively. Therefore, to test the effects of shifts in peak wavelengths of the
LEDs, simulation experiments were conducted where individual LED spectra
were shifted by the desired amounts and photodetector ratios

φBF
φ
and BP were
φBP
φG

calculated according to eq. 8 in section 2.2.1 and eq. 11 in section 2.2.2
respectively. The generated values of

φBF φBP
,
were substituted in eqns. 1 and 2
φBP φG

above respectively to generate the values of MPOD and LEA. The fitting
coefficients used were based on the original spectra of the component LEDs.
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Section 4.3
Simulations
First we tested for the level of differences in the peak values of MPOD obtained
because of shifts in the peak wavelengths of the component LEDs. We began by
calculating the effect of a peak wavelength shift in the blue LED keeping the
spectrum of the green LED the same. However no alteration was made to the
microprocessor code to reflect such a shift. When purchasing commercial LED
packs, a ± 5 nm variation in the peak wavelength is quite common. Therefore we
tested the level of differences that would be observed in the MPODs for subjects
with lens equivalent ages of 20, 40, 60 and 80 years when the blue LED peak
wavelength was shifted by +5 nm and -5 nm. The calculations were all made
using Sigmaplot. The integrals involved in eqns. (8) in section 2.2.1 and (11) in
section 2.2.2 for computing log

φBF φBP
,
(the photodetector readings for the
φBP φG

foveal and perifoveal measurements for the simulated LED pair) were evaluated
numerically using 0.5 nm wavelength intervals for the spectral components. The
values of log

φBF
were substituted in Eq. 1 above to get the new peak MPODs.
φBP

The effects on MPOD of the wavelength shifts are shown in Figs 4.1(a)- (d) for
the different LEAs, where the percentage difference in MPOD is plotted as a
function of the peak MPOD values.
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Fig.4.1a Variation in the percentage difference of MPOD observed for an
individual with an LEA of 20 years when the blue LED is shifted by 5nm. The
green line is for the variation observed when the blue LED is moved by +5 nm
and the red line is for the variation observed when the blue LED is moved by 5nm.
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Fig. 4.1b Variation in the percentage difference of MPOD observed for an
individual with an LEA of 40 years when the blue LED is shifted by 5nm. The
green line is for the variation observed when the blue LED is moved by +5 nm
and the red line is for the variation observed when the blue LED is moved by 5nm.
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Fig. 4.1c Variation in the percentage difference of MPOD observed for an
individual with an LEA of 60 years when the blue LED is shifted by 5nm.The
green line is for the variation observed when the blue LED is moved by +5 nm
and the red line is for the variation observed when the blue LED is moved by 5nm.
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Fig 4.1d Variation in the percentage difference of MPOD observed for an
individual with an LEA of 80 years when the blue LED is shifted by 5nm. The
green line is for the variation observed when the blue LED is moved by +5 nm
and the red line is for the variation observed when the blue LED is moved by 5nm.
Effects of ± 5 nm shifts in the peak wavelength of the green LEDs were also
tested while keeping the spectrum of the blue LED the same as for which the
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microprocessor was programmed. The effects of the shift in the green LEDs were
tested for individuals possessing LEAs of 20, 40, 60 and 80 years just like the
ones tested for shifts in the blue LED. The effects of such testing are shown in
Fig.s 4.2(a)-d.
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Fig 4.2a Variation in the percentage difference of MPOD observed for an
individual with an LEA of 20 years when the green LED is shifted by 5 nm. The
green line is for the variation observed when the green LED is moved by +5 nm
and the red line is for the variation observed when the green LED is moved by 5nm.
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Fig 4.2b Variation in the percentage difference of MPOD observed for an
individual with an LEA of 40 years when the green LED is shifted by 5 nm. The
green line is for the variation observed when the green LED is moved by +5 nm
and the red line is for the variation observed when the green LED is moved by 5nm
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Fig 4.2 c Variation in the percentage difference of MPOD observed for an
individual with an LEA of 60 years when the green LED is shifted by 5nm. The
green line is for the variation observed when the green LED is moved by +5 nm
and the red line is for the variation observed when the green LED is moved by 5nm.
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Fig 4.2 d Variation in the percentage difference of MPOD observed for an
individual with an LEA of 80 years when the green LED is shifted by 5nm, The
green line is for the variation observed when the green LED is moved by +5 nm
and the red line is for the variation observed when the green LED is moved by 5nm.

As mentioned in chapter2, Mapcatsf computes the lens density interpreted as
lens equivalent age, LEA, from the luminance of the blue and the green LEDs at
perifoveal flicker null settings according to the Eq.11 in section 2.2.2 followed by
Eq. 2 in section 4.2 above. The capacity to compute the LOD and interpret it in
terms of the LEA is a novel feature not available in other similar HFP
instruments. Hence just like the effect of a shift in peak wavelength of the
component LEDs on the measured values of the MPOD, similar testing was
pursued to see the effects on the LEA. The ratio of the photodetector settings was
calculated for the perifoveal flicker null conditions as mentioned above for the
simulated peak shifted LED pair. The calculated values were substituted in Eq.2
of section 4.2 to obtain the LEA, but the coefficients in Eq. 2 were kept at values
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used for obtaining LEA for the original LED pair used in the instrument. At first
the green LED spectrum was shifted by ± 5 nm while leaving the spectrum of the

Percentage Difference in LEA

blue LED unaltered. The results of such testing are shown in Fig 4.3.
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Fig 4.3 The percentage differences in LEA due to shift in the green LED by ± 5
nm. The green line is for the percentage differences in the LEAs that will be the
result when the peak of the green LED is moved by+5nm. Similarly the red line is
for the percentage difference in the LEA that will result when the green LED is
moved by -5nm.

Further, the effect of a 5 nm shift in the peak wavelength of the blue LED on LEA
was tested while having the spectrum of the green LED unaltered. The effect of
such a shift is shown in Fig.4. Referring to Figs. 4.3 and 4.4 we can see that the
shift in the blue LED would affect the LEA measurement more than an equal shift
in the peak of the green LED.
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Fig.4.4 The percentage differences in LEA due to shift in the blue LED by ±
5nm. The green line is for the percentage differences in the LEAs that results
when the peak of the blue LED is moved by+5nm. Similarly the red line is for the
percentage difference in the LEA that will result when the blue LED is moved by
-5nm.
Five nanometer shifts being quite common in commercial LED packages, from
our intuition, a 1nm shift in the peak of the LED was believed to be a more than
likely occurrence. While such a shift may not be significant for other purposes,
we were nonetheless prompted to test its effects on MPOD and LEA
measurements based on the range of differences observed with 5 nm shifts in the
component LEDs. The testing for the effects of ±1 nm shifts on both the MPOD
and LEA measurements were executed in the similar manner to those for the
±5nm shifts. The testing for the effects on the MPOD measurements was again
tested for simulated individuals with LEAs of 20, 40, 60 and 80 years old. The
results are shown in Figs 4.5 a-d respectively.
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Fig. 4.5 a Variation in the percentage difference of MPOD observed for an
individual with an LEA of 20 years when the blue LED is shifted by 1nm.The
green line is for the variation observed when the blue LED is moved by +1 nm
and the red line is for the variation observed when the blue LED is moved by 1nm.
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Fig. 4.5 b Variation in the percentage difference of MPOD observed for an
individual with an LEA of 40 years when the blue LED is shifted by 1nm.The
green line is for the variation observed when the blue LED is moved by +1 nm
and the red line is for the variation observed when the blue LED is moved by 1nm.
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Fig 4.5 c Variation in the percentage difference of MPOD observed for an
individual with an LEA of 60 years when the blue LED is shifted by 1nm.The
green line is for the variation observed when the blue LED is moved by +1 nm
and the red line is for the variation observed when the blue LED is moved by 1nm.
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Fig 4.5 d Variation in the percentage difference of MPOD observed for an
individual with an LEA of 80 years when the blue LED is shifted by 1nm.The
green line is for the variation observed when the blue LED is moved by +1 nm
and the red line is for the variation observed when the blue LED is moved by -1
nm.
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Similar effects resulted from 1 nm shifts in the green LED were investigated, and
the results are shown in Fig.s 4.6 a-d.
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Fig 4.6 a Variation in the percentage difference of MPOD observed for an
individual with an LEA of 20 years when the green LED is shifted by 1nm. The
green line is for the variation observed when the green LED is moved by +1 nm
and the red line is for the variation observed when the green LED is moved by -1
nm.
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Fig 4.6 b Variation in the percentage difference of MPOD observed for an
individual with an LEA of 40 years when the green LED is shifted by 1nm. The
green line is for the variation observed when the green LED is moved by +1 nm
and the red line is for the variation observed when the green LED is moved by -1
nm.
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Fig 4.6c Variation in the percentage difference of MPOD observed for an
individual with an LEA of 60 years when the green LED is shifted by 1 nm. The
green line is for the variation observed when the green LED is moved by +1 nm
and the red line is for the variation observed when the green LED is moved by -1
nm.
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Fig4.6d Variation in the percentage difference of MPOD observed for an
individual with an LEA of 80 years when the green LED is shifted by 1nm. The
green line is for the variation observed when the green LED is moved by +1 nm
and the red line is for the variation observed when the green LED is moved by -1
nm.

54

Testing was also conducted for the effect of a shift in the LED peak wavelengths
by ± 1 nm on the LEAs measured. The results obtained for the shifts in the blue
and the green LEDs are shown in Fig.s 4.7 and 4.8 respectively.
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Fig 4.7 Variation in percentage difference in LEA due to shift in the blue LED by
± 1 nm. The green line is for the percentage differences in the LEAs that results
when the peak of the blue LED is moved by+1 nm. Similarly the red line is for
the percentage difference in the LEA that will result when the blue LED is moved
by -1 nm.
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Fig 4.8 Variation in percentage difference in LEA due to shift in the green LED
by ± 1nm. The green line is for the percentage differences in the LEAs that
results when the peak of the green LED is moved by+1nm. Similarly the red line
is for the percentage difference in the LEA that will result when the green LED is
moved by -1 nm.
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Section 4.4
Discussion
The results of the simulated experiments conducted by shifting the LED peaks
indicate significant effects on both the MPOD and the LEA measurements. The
effects on MPOD measurements due to the shifts in either of the component LED
spectra are seen to be dependent on the age of the subject or more precisely
his/her LEA. At first we tested the effects of ±5 nm shifts of the component LED
spectra. The effects for the ±5 nm shifts in the green LED spectrum while having
the blue LED spectra fixed, on MPOD measurements were shown in Figs 2.1 a- d.
Similarly effects on MPOD measurements because of ±5 nm shifts in the blue
LED spectra, but having the green LED spectra fixed were shown in Figs. 2.2 a-d.
On inspection of the two sets of graphs we can observe that the overall effects are
more pronounced with the increase in the associated LEAs of the subjects. Aside
from an age-related effect, shifts in the green LED seem to be affecting each age
group more than similar such shifts for the blue LED. Capacity to measure the
lens density being a novel, ancillary feature of Mapcatsf, we tested the effects of
±5 nm shifts in the peak wavelength for both the green and the blue LEDs on the
LEA as percentage differences. Such simulated testing evolved a reverse trend,
based on the effects observed in Fig.s 4.3 and 4.4 where we observe that shifts in
the blue LED source affected the values of LEAs more than similar such shifts in
the green LEDs, contrary to the effects of the ±5 nm shifts on MPOD
measurements.
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As mentioned in the earlier sections of this chapter, ±1 nm shifts were assumed to
be a more likely occurrence in a commercial LED pack than ±5 nm variations.
From similar such tests as those conducted for the ±5 nm shifts, the results of the
±1 nm shifts of both the component LEDs on the MPOD and LEA measurements
are shown in Figs 4.5(a)-(d), 4.6 (a)-(d), 4.7, 4.8 . The effects are shown as
percentage differences in MPODs that are outcomes of the ±1 nm shifts in the
peak wavelength of the blue LED in Figs. 4.5 (a)-(d). Similarly effects due to ±1
nm shift in the green LED are shown in Figs. 4.6(a)-(d). Figs. 4.7 and 4.8 depict
the effects on LEA measurements due to shifts of magnitude ±1nm in the blue and
the green LED spectra respectively.
On inspection of the Figs. 4.5 (a)-(d) and Figs. 4.6 (a)-(d) we can infer an increase
with LEA in erroneous outcomes due to shift in the component LED spectra on
MPOD measurements. As expected, the percentage differences in the MPOD
values observed are less compared with those observed for the ±5 nm shifts at the
same LEA. Similar to the 5 nm shifts, a 1nm shift in the green LED has more
effect on MPOD measurement compared to a similar such shift of the blue LED,
for the same LEA. However, similar to the 5nm shifts, the percentage differences
in LEA measurements are seen to be more affected with the shift in the blue LED
than with shifts of similar magnitude with the green LED.
Trends observed in the plots depicting the effects on MPOD measurement due to
both the ±5nm and ±1 nm shifts in peak wavelengths of each of the component
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LED spectrum makes it inconclusive to comment which direction of shift in the
spectra has a more pronounced overall effect than the other.
In Fig 4.3 one can observe that the effect of a +5nm shift in the green LED peak
has a lower effect than a -5 nm shift on the LEA measurements. However in case
of Fig. 4.8 the effects of ±1 nm shifts in the green LED on LEA measurements
cannot lead to an inference as to shifts in which direction of the spectrum of the
green LED might lead to less margin of error.
On observing Fig 4.4, we can again comment that a +5 nm shift in the blue LED
has less effect than a -5 nm shift on LEA measurements. The effects of shifts in
the blue LED spectrum by ±1 nm shown in Fig. 4.8 again cannot aid in making a
conclusive comment whether a positive or a negative shift in the peak of the blue
LED by 1nm might have more effect on the LEAs measured.
In conclusion, since we have observed a significant variation in both the MPOD
and the LEA due to shifts in the component LEDs by even 1nm, if the LEDs need
to be replaced, care should be taken that their spectrum is not shifted even by 1
nm from that of either of the component LEDs for which the microprocessor was
originally programmed. Further, in our opinion, it will actually be better to reprogram the microprocessor if the LEDs are replaced, taking into account their
precisely measured spectra so that erroneous values of MPOD and LEA are not
obtained.
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5. Chapter 5
Variation of Peak Macular Pigment Optical Density with Age measured
using Heterochromatic Flicker Photometry

Section 5.1
Introduction
Researchers over the years have reported various trends of an overall variation of
MPOD with age of the subjects. Some have reported an overall rise,68,69,70 some
an overall decline57,67, or some no change at all33,71 ,72. However, especially for the
investigators employing HFP, a majority of them have reported an overall
negative relationship between age and MPOD58,57 ,32 ,73. After an investigation of
the various instruments used when MPOD was measured by HFP, we observed
that the developers of these instruments74,41 had not taken into account the
changes in the luminous efficiency of an individual with age. The change in the
luminous efficiency with age is primarily observed in the lower wavelength
region of the visible spectrum;52 such a change therefore can be attributed mainly
to the change in the optical density of the lens with age.62,52,46 We conducted an
experiment in order to test if an apparent age-related decline in MPOD, similar
to those reported by other researchers using HFP, can be explained as a result of
overlooking the age-related variation

in luminous efficiency function in the

instruments used.
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Sets of unbiased random numbers were used to simulate subjects' MPOD and
LEA. The simulated data were used to compute the photodetector ratio

φB F
φ BP

which was then used in eq.1 in section 4.2, but with the fitting coefficients kept
fixed for those of an individual aged 32 years, to compute the value of “partially
corrected” MPOD.
Section 5.2
Theory
Fig. 5.1 below shows the age-corrected luminous efficiency function V10 ( λ ) , for a
centrally viewed 10-degree stimulus, corrected for age using the template
suggested by Sagawa and Takahashi. The functions V10 ( λ ) when age-corrected
are termed V10 ( λ , a ) , with the parameter “ a ” depicting the LEA as explained in
detail in chapter 2. On inspection of these functions, more pronounced age-related
changes are observed in the lower wavelength region (400 to 550 nm) than in the
higher wavelength region.
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Fig 5.1 The age corrected luminous efficiency function for a centrally viewed 10
degree stimulus.

On inspection of the Eq.s given in chapter 2 used for computing the ratio between
the photodetector outputs, which are subsequently used to compute the MPOD
values, we can clearly observe that the age-corrected luminous efficiency function
plays an integral role.
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Fig.5.2 Plot of peak MPOD “P” with log  B F  for 50, 30 and 15 year olds.
 φB P 

The effect of having the fitting coefficients in the polynomial not corrected for
LEA is illustrated in Fig. 5.2 above. Here it can be seen that if an individual of 30
φ 
years of age gave a log  B F  value of 0.5, following the curve for the associated
 φB P 

LEA of that of 30 years, the MPOD would be computed as 0.78 by the
φ 
microprocessor. If a subject with an LEA of 50 years gave the same log  B F  of
 φB P 
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0.5, the peak MPOD would be computed as 0.89, and someone with an LEA of 15
φ 
years would give a true MPOD of 0.74 for the same log  B F  value of 0.5.
 φB P 

Section 5.3
Experiment
We generated unbiased random numbers using Sigmaplot® to simulate peak
MPOD values between 0 and 1, and LEA values between 20 and 90 years. See
Fig. 5.3. The values of peak MPOD show no dependence, on average, with age as
is evident from the slope of the regression line which is 5.736x10-5density
units/year.
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Fig 5.3 The scatter plot of simulated peak MPOD values with the LEAs generated
from random numbers.
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φ 
Employing eq. 8 in section 2.2.1, the log  B F  values were calculated for each
 φB P 
φ 
individual on Sigmaplot. The calculated values of log  B F  are plotted with
 φB P 

respect to the LEAs in Fig 5.4.

The peak MPOD obtained by Mapcatsf is

φ 
computed from log  B F  using eq. 1 in section 4.2. The coefficients in the Eq.
 φB P 
are dependent on the LEAs of the individuals obtained from eq. 2 in section 4.2.
Therefore, to test the effect of the invariance in the luminous efficiency function,
we kept the values of the coefficients, Yo, a, b, c for those of a 32 year old
individual, hence giving “partially corrected” values of MPOD. Such an age was
selected because the standard luminous efficiency curve approved by the CIE is
based on the data gathered from a group of subjects where the average age was 32
years.75
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Fig 5.4 Plot of log  B F  values versus LEAs generated from random numbers
 φB P 
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Six independent data sets were generated similar to that described by Fig. 5.3 and
φ 
the simulated values of log  B F  were calculated in the same manner as
 φB P 

described above. Following this, the calculated values were partially corrected as
mentioned above to obtain the MPOD values if the age correction for the
luminous efficiency function is not incorporated. An example of a test run is
given in Fig.5.5.
The regression analysis conducted on the plots of MPOD vs generated LEA for 6
simulated datasets gave an average decline in MPOD of (1.44 ± 0.51) × 10

−2

per decade.
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Fig 5.5 Scatter Plot of MPOD with age generated from random Nos. The red dots
or the “partially corrected” MPOD values are obtained when the values of
are log φBF  used for the polynomial fit with coefficients fixed for that of a 32
 φBP 

year old in eq.1 in section 4.2. The red line gives the regression analysis of the
variation of MPOD with age. The black dots depict the true simulated MPODs
values of the subjects generated from the random numbers on Sigmaplot.
We can observe in Fig.5.5 that the “partially corrected” MPOD values for the
simulated subjects in the higher age range (> 32 years) have lower calculated
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values of peak MPOD than their actual values represented by the black dots, and
the partially corrected MPOD values for the subjects in the lower age group (< 32
years) have higher values compared to their actual peak values of their MPODs.
Such a trend can be explained based on the assumed invariance in the luminous
efficiency function with age.
Section 5.4
Discussion and Conclusion
The average decline in peak MPOD with age per decade as observed from the
average of the slopes of the six simulations was of the same order of magnitude as
those reported by other researchers who had analyzed the MPOD measured by
heterochromatic flicker photometry (HFP) as a function of subject age.57,58,59,73
Hence we can surmise that MPODs measured using broad-band light sources,
especially LEDs, can give potentially erroneous results if the changing levels of
the luminous efficiency function with age are not taken into account. The
resultant discrepancies are more pronounced in the higher age groups than the
ones observed in the younger age groups.
Mapcatsf takes into account the age-related changes in the luminous efficiency
function. Hence for the same population of subjects tested for repeatability in
Chapter 3, data was analyzed by plotting a scatter plot of the average MPOD
obtained from test and retest versus the lens equivalent age as shown in Fig. 5.6.
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Fig.5.6 The plot of MPOD measured versus the LEAs measured while testing for
repeatability of Mapcatsf. The regression line has Eq. of the y=0.352+3.155×103
x.

The slope of the regression line in Fig 5.6 gave an overall rise of MPOD of
3.15×10-2 per- decade with a p-value of less than 0.03 and r2 value of 0.061.
Recruitment of subjects was not controlled, based on lifestyle, especially diet.
However, it might be possible that individuals in the higher age groups were
consuming a more healthy diet rich in carotenoids, especially lutein and
zeaxanthin. This possibility might be responsible for the observed rise in MPOD
with age. Nevertheless, based on the statistics and the recruitment profile, a firm
conclusion cannot be inferred.
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The negative trends in the variation of MPOD with age that we observed for the
simulated data sets along with the positive slope of the regression line for Fig 5.6,
does not lead us to a firm conclusion about the variation of MPOD with age.
Researchers should therefore be cautious about the various factors such as dietary
habits and levels of UV exposure of the subjects involved before predicting an
age-related trend in the level of optical density of MP, particularly if it is
measured by LED-based HFP instruments.
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6. Chapter 6
Validity of Mapcatsf’s capacity to measure lens optical density
Section 6.1
Importance of developing reliable lens density measuring techniques
Cataract, manifested by the ocular lens becoming heavily opaque,76 is one of the
major causes of visual impairment in the world.77 The primary structures of the
lens which undergo changes in the optical density and potentially exhibit the
condition of cataract are the cortex, nucleus and posterior sub-capsular (PSC)
regions of the lens.78,79 Different reasons account for the accelerated increase in
the optical density of these three regions of the lens. The component protein
molecules undergoing changes in shape is primarily associated with the changes
in the optical density of the nucleus, whereas the stress in the associated lens
fibers is responsible for the rise in optical density levels of the cortical region.76
However opacity levels in the PSC region are considered mainly to be associated
with diabetes, myopia, exposure to ionizing radiation and intake of steroids.79 The
optical density changes in the nucleus and the cortical regions have been found to
be age-related.80 Aside from age and genetic81 factors being key reasons for
progress towards cataract, reasons from which one can safeguard oneself, such as
smoking,82 UV exposure,83 and obesity have been found to be responsible for
development of cataract not only in the elderly but also in younger individuals.
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Since accelerated rise in the optical density of the ocular lens is considered a
predictor of progression towards cataract, regular monitoring of the density levels
of the lens is of vital importance.56 Hence, development of fast, easy, noninvasive, reliable methods for measuring lens density under clinical settings is
necessary.84 Some examples of measurement techniques that are signal-based and
directly measure the optical density of the lens are autofluorescence85 and
reflectance techniques.86 However, these techniques are associated with serious
drawbacks. The autofluorescence technique is expensive and the signal obtained
is found to be heavily affected by scattering of light by the aging lens.38 Similarly
the signal obtained by reflectance techniques is susceptible to being compromised
by the presence of drusen especially in the aging retina.38 Psychophysical
techniques on the other hand employ photopic or scotopic vision and involve
minimal risk. Additionally one can neglect the loss of signal due to scattering of
light by the aging lens.
Psychophysical techniques employing photopic vision are fast and easy but are
dependent on the response of the associated cone cells in the retina. Popular
methods employing photopic vision are heterochromatic flicker photometry
(HFP)87 and color matching techniques.88 These techniques employ the photopic
luminous efficiency function which is directly dependent on the weighting of the
long wavelength sensitive L-cones and medium wavelength sensitive M-cones.89
It is known that the relative weights of L-cones and the M-cones vary
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significantly amongst individuals. Therefore data for ocular parameters measured
employing these techniques have been questioned for reliability.56
Scotopic vision, mediated by the rod cells, has been used by Wald in 194514 and
Wright in 195190 to compute the lens density spectrum by comparing the scotopic
sensitivity curves of phakic and aphakic individuals. The differences they
reported were attributed to the transmittance of the crystalline lens in the phakic
individuals. Further, the scotopic luminous efficiency functions of the aphakic
individuals had a close resemblance to the rhodopsin absorption spectrum.
Therefore a comparison between the rhodopsin absorbance spectrum and the
scotopic luminous efficiency function at absolute thresholds of vision can be used
to compute the lens density spectrum for phakic individuals.62 Testing at absolute
thresholds necessitates prolonged periods of dark adaptation making the testing
very lengthy. However, results obtained under such conditions are found to be
consistent with those obtained by ex-vivo techniques.56 Rod mediated scotopic
vision is dependent on the rhodopsin absorbance template, which is almost
constant in individuals, unlike photopic vision with its dependence on the
weighting of L-cone to M-cones. Hence to establish the reliability of LEA
measurements by Mapcatsf, we compared the LEA for a group of individuals
tested on Mapcatsf to their LEA values obtained at absolute scotopic thresholds
after complete dark adaptation. A detailed description of the theory and testing
procedure of lens density measurement by Mapcatsf can be found in chapter 2,
section 2.2.2 and 2.3 respectively.
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Section 6.2
Scotopic Measurements: Theory
Vision taking place under light conditions of -2.5 log Trolands falls in the
category of scotopic vision and is mediated by rod cells.91 The spatial density
distribution of the rods is such that the fovea can be considered a rod-free zone
but there is an increase in rod density with increasing eccentricity from the fovea,
reaching 190,000 rods/mm2 at 20 to 30 degrees from the fovea.92 Taking into
account that above 5 degrees eccentricity density of MP is negligibly small, the
scotopic luminosity function above 5 degrees is affected only by the transmittance
spectrum of the lens TL ( λ ) and the rhodopsin absorbance spectra R ( λ ) .93

Vs cot opic = R ( λ ) TL ( λ ) ........(1)
TL ( λ ) was calculated for that of a 32 year old person using the van de Kraats
and van Norren template and corrected for age by the template suggested by
Sagawa and Takahashi.52 The absolute thresholds of vision were tested for a
peripherally viewed stimulus illuminated by either a blue or a green LED, similar
to those used for the perifoveal testing on Mapcatsf. The stimulus for the scotopic
measurements was designed to be positioned at approximately the same retinal
eccentricity as the periphery of the 15º degree stimulus on Mapcatsf.

The

rationale was that any traces of MP at this eccentricity would affect each method
of measurement equally. The similar LED sources and the eccentricity of the
perifoveal stimulus used enabled direct comparison between the LEAs obtained
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by the two separate methods. The luminances of the stimulus due to the blue and
the green LEDs, LB , LG are mathematically expressed in Eq.s (2) and (3)
respectively.
LB =  B ( λ )TF ( λ ) Tw ( xb , λ ) R ( λ ) TL ( λ , a ) d λ .................(2)

LG =  G ( λ )TF ( λ ) Tw ( xg , λ ) R ( λ ) TL ( λ , a ) d λ ................(3)

The terms B (λ ) , G ( λ ) denote the normalized spectra of the blue and the green
LEDs respectively. The spectra of both the LEDs were obtained using the Ocean
Optics® spectrometer. The transmittance of an auxiliary neutral density filter
placed in the path of the testing light to maintain full scotopic viewing condition
is denoted by TF ( λ ) . The terms Tw ( xb , λ ) , Tw ( xg , λ ) are the transmittances of a
variable density neutral wedge at the translational settings xb and xg , at which the
absolute scotopic thresholds are detected for the blue and the green LEDs
respectively. Since, at absolute threshold, the luminance values are equal - both
are essentially zero - we get:
−1.2036 xg
10
 B ( λ ) TF ( λ ) Tw ( xb , λ ) R ( λ ) TL ( λ , a ) d λ ......(4)
0.59
=
10−1.1364 xb
 G ( λ ) TF ( λ ) Tw ( xg , λ ) R ( λ ) TL ( λ , a ) d λ

The factors 1.2036, 1.1364 and 0.59 appearing in eq. (4) are the result of
calibration of the variable density wedge and the LED sources.
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On observation, the right-hand side of Eq. (4) gives a unique value for a particular
value of “ a ”. Therefore by varying the values of LEA,“ a ”, we can generate
values of the right-hand side. Labeling the left- hand side of Eq. 4 above as “ F ”,
we can obtain a plot of LEA with respect to F, and this is shown in Fig.6.1. The
plot of LEA vs F shown in Fig. 5 was fitted with a function of the form given in
Eq. 5 to enable computation of LEA from F.

LEA =

a + bF
……………..(5)
1 + cF + DF 2

Fig.6.1 The polynomial fit to the plot of LEA with F.
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Section 6.3
Scotopic Measurements: Instrument design
The peripheral stimulus with the provision of central gaze fixation is shown in
Fig. 6.2. The 0.5 degree stimulus is set 7.5 degrees eccentric to the central gaze
position which is facilitated by a dimly lit red LED of 0.25 degrees radius. The
stimulus in the periphery is illuminated by a blue LED of peak wavelength 455
nm or a green LED of peak wavelength 515 nm. The input to the LEDs was
provided by a frequency-controlled circuit so as to prevent variation in peak
wavelengths with change of intensity. The driver associated with feeding the input
signal to the LED generated pulses in the kilohertz range. The LEDs being cycled
at 0.5 s “on” and 1.0 s “off” resulted in the visual perception of pulses of short
duration.

Fig. 6.2 The central gaze fixating stimulus used for absolute scotopic threshold
measurements.
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The optical layout for the setup for scotopic measurement is shown in Fig 6.3.
The sphere S acts in the capacity of an integrating sphere housing the test LEDs in
the upper interior section, providing spatially uniform light emerging from the
aperture. To maintain scotopic viewing conditions, a series of neutral density
filters were placed in the light path between the sphere “S” and the eyepiece. The
variable density wedge filter was translated electromechanically to alter the
luminance levels of the test LEDs to reach the absolute scotopic threshold. The
opaque screen to the left of the housing for the eyepiece consisted of precisely cut
apertures defining the stimulus and the fixation target. Also posterior to the
opaque screen, the dim red LED is placed to illuminate the fixation target. An
achromatic doublet lens is positioned to the right end of the housing which can be
moved back and forth in a telescopic arrangement. As explained in section 2.1
(Fig. 2.3), to ensure the maintenance of eccentricity at which the image of the
stimulus is formed in the retina of the subject, a non-limiting viewing aperture is
positioned so that the distance between the nodal point of the subject’s eye and
the achromatic doublet lens is equal to its focal length.43
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Fig. 6.3 The layout and optical setup for the scotopic lens density measurement
Section 6.4
6.4.1 Design and Plan of the Study
Twenty five subjects were recruited between the ages of 20 and 75 years (average
age 39±14 years) and were in possession of healthy vision. They were required to
sign FIU-IRB approved informed consent.
Lens densities were measured for the subjects recruited by the two methods. Since
the lens densities are usually similar in both the eyes, only one eye was tested.56
6.4.2 Photopic Testing
As the lens densities or LEA measurements by Mapcatsf are obtained from the
perifoveal flicker null measurements, the testing procedure was the same as
discussed in chapter 2 section 2.3, or in the section where the testing procedure is
discussed in Bone and Mukherjee.43
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6.4.3 Scotopic Testing
The subjects were fully dark-adapted for 30 minutes in a room of complete
darkness. However, prior to dark adaptation, the eyepiece lens was adjusted to
bring the fixation target and the peripheral stimulus into sharp focus. During the
period of dark adaptation, a further precaution was taken to occlude the subject's
test eye with an eyepatch. Once fully dark adapted, the operator turned the
blinking blue stimulus “on” with the subject being directed to gaze at the
minimally lit red LED. Such a direction from the operator ensured the blinking
stimulus appeared in the periphery of the subject’s viewing field. The wedge
setting initially was set at a level such that the luminance of the stimulus was
higher than at threshold. Consequently the subjects counted all 14 blinks that
occurred during a 20 seconds measurement period. The intensity of the testing
stimulus was lowered incrementally by translating the variable optical density
wedge. The subject was allowed 20 seconds to report the number of blinks that
were seen at each setting of the wedge. The test was terminated when the subject
started reporting around 2 blinks for the span of 20 seconds. Subsequently the
blue LED was replaced by the green LED and the procedure was repeated.
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Section 6.5
Results:
A scatter plot was generated between the number of counts and the wedge
positions. A three parameter sigmoidal function shown in Eq. 6 below was fitted
to the data.

a

N=
1+ e

−

( x − xo )
b

.......(6)

In Eq. 6 “N” is the number of counts and the variable x depicts the variable
density wedge position. A 50 % visibility criterion was used for obtaining the
wedge setting at absolute scotopic threshold. The criterion reflects the setting at
which 50% of the blinks were visible. The values of threshold settings obtained
from Eq. 6 were substituted in the left-hand side of Eq. 4 to obtain the quantity F
which, when substituted in Eq.5, gave us the LEA. The uncertainties in
measurement of the scotopic LEAs were associated with the uncertainty generated
for the parameter

xo

in Eq.6 on Sigmaplot.
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Fig 6.4 A sample scatter plot obtained for a participating subject for one of the
LEDs tested. The inverse sigmoidal curve of the form as given in Eq.(6) was
fitted to obtain the absolute scotopic threshold at the 50 % viewing criterion.

The scatter plot for the photopic LEA versus the scotopic LEA is shown in Fig.
4.5. The error bars associated with the data points are the standard errors in
measurement of LEAs under the two separate viewing conditions respectively.

Fig 6.5 The scatter plot of photopic LEAs obtained from Mapcatsf versus the
scotopic LEAs obtained at absolute threshold. The solid line is of slope unity. The
dashed line is the regression line of Eq. y=0.833x+3.945.
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The solid line of slope unity represents equality between the LEAs obtained under
the two separate viewing conditions. Results of regression analysis of the scatter
plot in Fig 4.5 gave a slope of 0.8333 and an r2 value of 0.59 with p < 0.0001.To
further analyze the gathered data for systematic deviations, we performed a Bland
Altman analysis as shown in Fig. 6.6. The mean difference between the photopic
and the scotopic LEAs was 2.00 years with 8.68 years being the 95 percent
confidence intervals.

Fig 6.6 The Bland Altman plot used for testing for levels of agreement of the
results between the LEAs obtained under the two separate viewing conditions.
The mean difference which was 2.00 years is depicted by the solid horizontal line
and the dashed lines are for depicting Mean ±2SD.
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Section 6.6
Discussion
An overall good level of agreement between the LEAs measured by the two
methods can be surmised from the slope of 0.833±0.144 and the intercept of 3.945
years of the regression line in Fig.6.5. The average difference between the
photopic and the scotopic LEAs being 2 years with the limits of agreement being
8.0 years further supports our findings.
Wooten et al56 had reported a slope of 0.92 and an intercept of 0.09 density units
for the regression line for a scatter plot of lens densities obtained under photopic
and absolute scotopic viewing conditions. Our measurements were in terms of
LEA, but LEA is proportional to the optical density of the lens. Therefore we can
conclude that our results of regression analysis of Fig.6.5 compare favorably with
Wooten et al 2007. These researchers had proposed an alternate approach of
testing involving vision mediated by the rod cells, but only necessitating partial
dark adaptation. However they had suggested the possibility of some participation
of cone cells under such conditions. Therefore to avoid any cone intrusion, the
absolute scotopic thresholds were tested after complete dark adaptation.
Mapcatsf uses an age-modified 10º photopic luminous efficiency function.
Photopic vision is dependent chiefly on the responses of the L-(long) and M(medium) wavelength cones, and the ratio of the L- to M-cones is known to vary
over a wide range among individuals. Some of the reported ranges of variation in
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L and M cone ratios are 0.6 to 12 by Carroll et al.,61 1.1 to 16.5 by Hofer et al.,60
and 0.47 to 15.82 by Sharpe et al.89 The standard CIE 10º luminous efficiency
function is based on an average L to M cone weight. Hence measurement of LEA
employing photopic methods can be influenced by the variation in L and M cones
among individuals. To investigate the effect of the variation in cone weights on
the LEAs measured by Mapcatsf, we used the template developed by Sharpe and
Stockman89 which enables constructing the 10º luminous efficiency function for
any value of the L to M cone ratio. The ratio of photodetector intensities
provided by each subject allowed the LEA to be computed from Eq. (11) in
section 2.2.2. The only modification involved in the present case was replacing
the standard age-modified luminous efficiency function by a similar function at
the extreme cone weights of 0.47 and 16.5. For the extreme cone weights, the
lower extreme was the one reported by Sharpe and Stockman and the upper
extreme value was the one reported by Hofer et al. Table 6.1 depicts the results of
the analysis.
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Subject
No.

Age
(yrs.)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25

71
34
24
28
28
40
27
40
30
36
60
61
53
28
26
24
36
32
28
29
28
61
46
28
51

Measured
scotopic
LEA ±SD
(yrs.)

Measured
photopic
LEA±SD
(yrs.)

60 +/-5
43 +/-2
29 +/-2
37+/-1
28+/-3
47 +/-2
52 +/-7
48 +/-6
39 +/-9
48 +/-5
45 +/-5
64 +/-11
48 +/-3
23 +/-3
39 +/-3
36 +/-4
30 +/-5
44 +/-3
26 +/-1
24 +/-2
28 +/-3
38 +/-3
36 +/-3
29 +/-2
54 +/-4

69 +/-1
33+/-2
31+/-2
40+/-4
28+/-2
45+/-3
40+/-7
39+/-4
29+/-1
31+/-5
52+/-2
63+/-2
44+/-2
29+/-1
26+/-3
26+/-3
36+/-3
38+/-4
24+/-5
24+/-3
29+/-2
54+/-1
34+/-2
22+/-2
42+/-3

Photopic
LEA±SD
for L:M
weight of
0.47(yrs.)
75+/-1
41+/-2
39+/-2
43+/-4
31+/-1
49+/-3
44+/-8
44+/-5
37+/-2
34+/-4
57+/-2
68+/-2
48+/-3
33+/-1
29+/-3
29+/-5
45+/-2
42+/-4
29+/-4
29+/-4
33+/-3
57+/-2
37+/-2
28+/-3
44+/-2

Photopic
LEA±SD
for L:M
weight of
16.5(yrs.)
66+/-1
32+/-2
30+/-2
34+/-4
22+/-1
39+/-3
34+/-8
33+/-4
25+/-2
25+/-4
47+/-2
58+/-2
40+/-3
22+/-2
20+/-3
20+/-5
35+/-2
32+/-4
18+/-4
20+/-4
23+/-2
47+/-2
27+/-2
17+/-3
33+/-2

Table 6.1. LEAs measured under the two separate viewing conditions are
presented. The columns 5 and 6 consists the recalculated LEAs at extreme cone
weights of 0.47 and 16.5 respectively.
A two tailed Student’s t-test was conducted at the 0.05 confidence level to test the
significance of difference between the LEAs measured by Mapcatsf and at
absolute scotopic threshold. Such a testing resulted in 14 subjects having a
significant difference in their LEAs. For these 14 subjects the Student’s t-test was
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repeated, but their photopic LEA value was selected at the extreme cone weight,
which placed it closer to the LEA at absolute scotopic threshold. With this
modification, significant differences remained for 6 of the subjects. These 6
subjects were subjects 1, 10, 15, 16, 22 and 25. Therefore we can say that
variability in cone weight cannot completely account for the differences observed
between scotopic and the photopic LEAs.
As a concluding perspective, the results of LEAs measured under the two separate
viewing conditions are in reasonable agreement with previously published
results.56 Testing under scotopic conditions necessitates long periods of dark
adaptation especially if testing is preferred at absolute threshold conditions.
Therefore the rapid testing under photopic conditions would be recommended as
the preferable choice for routine measurements. Mapcatsf truly stands out as a
reliable instrument capable of measuring both MPOD and LOD/LEA with a high
level of repeatability for clinical purposes.
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7. Chapter 7
Credibility of Mapcatsf for Monitoring MPOD levels of an Individual
Consuming Lutein or Its Derivative Supplement for Six Months.
Section 7.1
Introduction:
Macular pigment being composed of xanthophylls, lutein, zeaxanthin and mesozeaxanthin,94 ,95,12 has been inferred to act in a protective capacity against photooxidative stress,96,97,

98

making it a vantage arena of research for vision scientists

in the past few decades.99, 100, 101,102
The level of MP possessed by individuals when measured by in-vivo methods is
expressed in terms of optical density (OD)102 or signal counts.103 A wide range of
variability in OD across individuals has been reported,104 along with the evidence
that individuals with higher levels of MPOD are at a lower risk of developing
AMD,105, 106,107 one of the leading causes of vision impairment affecting senior
individuals.108 The component carotenoids of MP are not produced by the human
body but can be assimilated through diet rich in them

101, 109

or via supplements

containing such carotenoids.110,111
Bone and Landrum have been pioneers in the arena of carotenoid research to
show that not only can supplements be used to elevate levels of MP but also
levels of MP reached at the end of the supplement consumption are not altered
significantly over the course of time.112 Their research involved monitoring levels

86

of MPOD at regular intervals by using heterochromatic flicker photometry (HFP)
in individuals consuming lutein.
Similarly, researchers or clinical practitioners, pursuing supplement studies,
primarily measure MPOD at regular intervals in individuals consuming the
supplement over the entire tenure of the study.113,114 Therefore developing
instrumentation methods providing a high level of precision is important in order
to properly monitor changes in the levels of MPOD during the course of such
studies.
HFP is one of the preferred means of measuring MPOD by researchers. The
primary intention of developing Mapcatsf, which is a novel LED-based HFP
instrument, has been to analyze and endorse its repeatability and credibility for
measuring and monitoring MPOD under clinical settings.
As reported in chapter 3, preliminary studies with 83 subjects have shown good
repeatability. However the credibility of Mapcatsf as an effective instrument for
use in clinical settings is further established by inferring its capacity to monitor
changing levels of MPOD in individuals. Such an attribute is established in this
chapter where we analyzed the MPOD values measured at regular intervals for
subjects consuming either lutein or the ester derivative of all the component
carotenoids making up MP over the course of six months.
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Section 7.2
Overview of the Supplements:
For the sake of comparison of responses in the levels of MPOD reached at the end
of six months, we used either of two supplements. Since there has been published
evidence that lutein and zeaxanthin are the ingredients that can significantly
boost the levels of MPOD in an individual,115,110 a supplement comprising
primarily lutein was chosen as one of the supplements and was labeled as “L”.
The lutein supplement used was derived from marigolds and was in the form of
gel-cap capsules with each capsule being 20 mg by dosage, and consisting of 95%
lutein and 5% zeaxanthin.
The other supplement was an ester derivative of lutein, zeaxanthin and
mesozeaxanthin which was labeled as “MicroMic”, manufactured by IOSA SA de
CV. The “MicroMic” supplement was also in the form of a gel-cap capsule and
consisted of 7mg of lutein, 7 mg of zeaxanthin and 7 mg of meso- zeaxanthin.This
supplement was tried since there has been evidence of such ester derivatives used
in chicken feed enhancing the coloration of poultry116 and egg yolk116. This
observation led to the hypothesis that it may be effective as a supplement to boost
the levels of the MP in humans.
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Section 7.3
Subject recruitment, profile and elimination criteria:
There were 32 subjects recruited for the study. Individuals recruited were in
possession of good ocular health and had to sign an FIU-IRB-approved informed
consent. To check the effect of age on physiological response to intake of
supplements, the total recruitment was divided into two age groups. One age
group consisted of 18 subjects between the ages of 18 and 30 years (younger
group) and the other group had 14 individuals of 50 years or older. Both the age
groups included males and females. The younger age group comprised 7 males
and 11 females of 23 ±3 (Mean ±SD) years. The older age group consisted of 9
males and 5 females of 58±8 (Mean± SD) years. Due to the established evidence
of smokers having a β -carotene-rich diet being at higher risk of developing
pulmonary cancer,117 care was taken that none of the subjects were smokers or
had a history of smoking. Further, caution was taken not to involve women who
were pregnant or had the likelihood of getting pregnant during the course of the
study.
Section 7.4
Design of Study
The study was designed for a total of 24 weeks. The subjects' MPOD values were
measured on Mapcatsf to provide the reference baseline value. They were then
provided with the supplements and the MPOD values were subsequently
measured at 8 week intervals for a total of 4 times during the entire duration of the
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study. The subjects were directed to consume one gel cap a day. They were
further instructed that if they missed the pill for one day, they could consume two
pills the following day. A printed schedule was also provided that had the followup dates when the subjects were required to get their MPOD tested.
Section 7.5
Testing Procedure
For a detailed overview of the testing procedure please refer to section 2.3.
Section 7.6
MPOD levels at 8 weeks interval
For each scheduled session, the entire test on Mapcatsf was conducted at least
twice, with each test involving 5 foveal and five perifoveal measurements. The
microprocessor associated with Mapcatsf computes the MPOD and the standard
error in the mean for each test. Since the testing for MPOD was done a minimum
of two times, with each measurement being independent of the other, the
weighted average of the tests and the standard error in the mean were obtained
from the formula:

x ±δ x =

 w x ±( w )

w
i i

i

i

i

i
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i

−1

2

............(1)

where

wi = 1

(δ xi )

2

..........................(2)

The terms xi and δ xi are the MPOD values and the errors associated with it for
the ith measurement, and the summation runs from 1 to N , the total number of
tests. As each measurement was independent from the other, a Gaussian
distribution could be assumed. The value of χ 2 =  wi ( x − xi ) was calculated
2

and its ratio to N − 1 was computed and compared to unity. The value N -1 is
considered the expectation value of χ 2 . If the ratio

χ2

N − 1 was found to be less

than one, we accepted the standard error of the mean, δx, as shown in Eq. 1. If it
was larger than one, we calculated the factor S and increased the error δ x in Eq.
1

2
 2 . This procedure is described in the article
(1) by a scale factor S =  χ

−
N
1


1975 by A.H. Rosenfeld in the “Annual Review of Nuclear Science” volume 25
page 555.
The data obtained for the subjects in each category based on gender and age are
presented in a tabular form. In tables 7.6.1 and 7.6.2, we present the value of the
MPODs recorded for the period of 24 weeks for male and female subjects
respectively in the younger age group.
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Subject
No.

Age
(yrs)

Baseline
(MPOD± SEM)

Week 8
(MPOD±SEM)

Week 16
(MPOD±SEM)

Week 24
(MPOD±SEM)

L1

24

0.882±0.011

0.874±0.012

0.830±0.022

0.928±0.014

L3

22

0.290±0.006

0.310±0.006

0.344±0.007

0.355±0.020

L4

22

0.367±0.012

0.427±0.008

0.507±0.012

0.514±0.013

L5

18

0.209±0.016

0.228±0.007

0.244±0.012

0.277±0.006

L9

20

0.528±0.010

0.476±0.015

0.554±0.011

0.598±0.013

L10

25

0.603±0.020

0.678±0.021

0.627±0.006

0.679±0.008

M3

30

0.322±0.015

0.316±0.006

0.338±0.009

0.3806±0.009

Table 7.6.1 The baseline and measured MPODs at 8 weeks interval of male
subjects between 18 and 30 years during the supplementation period. The subjects
on “Lutein” are titled as “L” and the one provided the “Micromic” are titled “M”.
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Subject
No.

Age
(yrs.)

Baseline
(MPOD± SEM)

Week 8
(MPOD±SEM)

Week 16
(MPOD±SEM)

Week 24
(MPOD±SEM)

L2

22

0.641±0.011

0.631±0.018

0.594±0.007

0.597±0.009

L6

22

0.614±0.010

0.653±0.008

0.707±0.017

0.680±0.008

L8

29

0.251±0.011

0.299±0.008

0.359±0.025

0.320±0.0231

L11

20

0.231±0.008

0.201±0.008

0.239±0.015

0.242±0.014

L12

22

0.488±0.014

0.537±0.013

0.536±0.022

0.589±0.017

M1

22

0.335±0.014

0.377±0.012

0.397±0.007

0.446±0.005

M2

24

0.184±0.014

0.146±0.011

0.153±0.009

0.172±0.012

M4

29

0.550±0.012

0.581±0.016

0.563±0.010

0.598±0.013

M5

22

0.237±0.008

0.282±0.007

0.304±0.004

0.334±0.008

M6

23

0.198±0.018

0.216±0.005

0.237±0.008

0.255±0.009

M7

22

0.210±0.013

0.284±0.007

0.347±0.015

0.347±0.009

Table 7.6.2 The baseline and measured MPODs at 8 weeks intervals of female
subjects between 18 and 30 years during the supplementation period. The subjects
on “Lutein” are titled as “L” and the ones provided the “Micromic” are titled
“M”.
Tables 7.6.3 and 7.6.4 represent the data obtained for the male and the female
subjects respectively in the older age groups.
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Subject
No.

Age
(yrs.)

Baseline
(MPOD± SEM)

Week 8
(MPOD±SEM)

Week 16
(MPOD±SEM)

Week 24
(MPOD±SEM)

M13

51

0.757±0.008

0.765±0.014

0.810±0.008

0.807±0.010

M15

61

0.601±0.006

0.587±0.007

0.558±0.006

0.597±0.015

L15

70

0.786±0.006

0.803±0.007

0.810±0.005

0.776±0.008

L16

61

0.430±0.010

0.407±0.006

0.402±0.012

0.461±0.062

L17

52

0.559±0.024

0.564±0.013

0.617±0.018

0.586±0.012

L18

51

0.505±0.008

0.519±0.015

0.518±0.007

0.573±0.010

L19

53

0.604±0.009

0.607±0.007

0.665±0.030

0.664±0.012

L20

52

0.664±0.010

0.666±0.009

0.714±0.014

0.701±0.103

L22

71

0.488±0.014

0.537±0.013

0.537±0.023

0.589±0.017

Table 7.6.3. The baseline and measured MPODs at 8 weeks interval of male
subjects 50 years or above during the supplementation period. The subjects on
“Lutein” are titled as “L” and the ones provided the “Micromic” are titled “M”.
Subject
No.

Age
(yrs.)

Baseline
(MPOD± SEM)

Week 8
(MPOD±SEM)

Week 16
(MPOD±SEM)

Week 24
(MPOD±SEM)

M14

55

0.442±0.009

0.432±0.008

0.433±0.009

0.474±0.012

L13

63

0.303±0.025

0.321±0.011

0.331±0.018

0.311±0.017

L21

51

0.224±0.010

0.241±0.009

0.264±0.006

0.291±0.021

L23

50

0.314±0.011

0.378±0.013

0.300±0.018

0.272±0.012

L24

53

0.448±0.009

0.489±0.009

0.469±0.009

0.486±0.018

Table 7.6.4 The baseline and measured MPODs at 8 weeks interval of female
subjects 50 years or above during the supplementation period. The subjects on
“Lutein” are titled as “L” and the ones provided the “Micromic” are titled “M”.
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Section 7.7
Response to the supplementation
To understand and compare the levels of responses of the subjects to the two
types of supplements used in the study, we performed the following analyses
presented in tables 7.7.1-7.7.4. We calculated the overall change in the MPOD,
which is the difference between the final weighted averages of the MPOD
associated with the weighted standard errors at the end of the 24 weeks and the
initial values of MPOD associated with the weighted standard errors labeled as
baseline. The percentage change in the MPOD levels at the end of the study was
also calculated along with the associated standard error of the mean. The
weighted values of MPOD obtained at 8 weeks intervals were plotted with respect
to the week number. The weighted slope of the regression line for the plot gave us
the rate of change of MPOD. The percentage compliance was calculated by
obtaining from the subjects the number of pills left on the day of the final
measurement and is represented as the percentage of the total number of pills
consumed.
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Subject
No.

Age
(yrs.)

Changes in
MPODand
SEM(d.u)

% Change in
MPOD and SEM

L1

24

MPOD
change
0.046

SEM
change
0.018

% change
in MPOD
5.24

SEM in
% change
2.03

L3

22

0.065

0.021

22.29

L4

22

0.148

0.018

L5

18

0.069

L9

20

L10
M3

Rate of
change of
MPOD
(d.u.)/week

Percentage
Compliance

0.001

88.2

7.23

0.003

93.6

40.27

4.98

0.006

92.4

0.017

32.90

8.64

0.003

99.4

0.074

0.016

13.34

3.16

0.003

99.4

25

0.076

0.012

12.65

3.53

0.003

81.1

30

0.058

0.018

18.16

5.71

0.003

91.8

Table 7.7.1 Response of male subjects in the younger age group to the supplement
consumption considering the baseline and final MPOD values from table 7.6.1.
The rate of change involves all the interim measurements done during the 6
month study.
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Subject
No.

Age
(yrs.)

Changes in
MPOD and
SEM(d.u)

% Change in
MPOD and SEM

Rate of
change of
MPOD
(d.u.)/week

Percentage
Compliance

L2

22

MPOD
change
-0.043

SEM
change
0.014

% change
in MPOD
-6.79

SEM in %
change
2.27

-0.002

93.6

L6

22

0.066

0.014

10.71

2.23

0.003

100

L8

29

0.069

0.026

27.52

10.34

0.004

100

L11

20

0.011

0.017

4.83

7.24

0.0004

93.6

L12

22

0.008

0.014

1.39

2.31

0.0005

100

M1

22

0.110

0.015

32.90

4.69

0.005

86.9

M2

24

-0.013

0.019

-6.85

-10.09

-0.0002

98.2

M4

29

0.048

0.018

8.73

3.26

0.0015

100

M5

22

0.097

0.011

40.82

5.01

0.004

100

M6

23

0.056

0.020

28.42

10.60

0.002

96.4

M7

22

0.137

0.016

65.04

8.78

0.0051

93.5

Table 7.7.2 Response of female subjects in the younger age group to the
supplement consumption considering the baseline and final MPOD values from
table 7.6.2. The rate of change involves all the interim measurements done during
the 6 month study.
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Subje
ct
No.

Age
(yrs.)

Changes in
MPOD and
SEM(d.u)

% Change in
MPOD and SEM

Percentage
Compliance

SEM in %
change
1.67

Rate of
change of
MPOD
(d.u.)/wee
k

SEM
change
0.013

% change
in MPOD
6.64

0.002

91

M13

51

MPOD
change
0.050

M15

61

-0.003

0.016

-0.54

-2.69

-0.002

99.4

L15

70

-0.010

0.010

-1.34

-1.28

0.002

100

L16

61

0.031

0.012

7.30

2.71

0.002

94.7

L17

52

0.026

0.027

4.73

4.83

0.001

99.4

L18

51

0.068

0.013

13.54

2.66

0.002

100

L19

53

0.059

0.015

9.79

2.45

0.003

99.4

L20

52

0.037

0.017

5.53

2.46

0.002

83.4

L22

71

0.102

0.023

20.84

4.68

0.004

98.2

Table7.7.3 Response of the male subjects in the older age group to the supplement
consumption considering the baseline and the final MPOD values from table
7.6.3. The rate of change involves all the interim measurements done during the 6
month study.
Subject
No.

Age
(yrs.)

M14

55

Changes in
MPOD
and SEM(d.u)
MPOD SEM
change change
0.032
0.015

% Change in
MPOD and SEM

L13

63

0.008

0.030

2.62

10.08

0.0005

94.7

L21

51

0.066

0.023

29.66

10.37

0.003

97.6

L23

50

-0.042

0.016

-13.37

-5.02

-0.002

93.5

L24

53

0.038

0.020

8.57

4.55

0.001

96.4

% change
in MPOD
7.35

Rate of
Change
(d.u.)/week

Percentage
Compliance

SEM in %
change
3.44

0.001

100

Table7.7.4 Response of the female subjects in the older age group to the
supplement consumption considering the baseline and the final MPOD values
from table 7.6.4. The rate of change involves all the interim measurements done
during the 6 month study.
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Supplement

Average change in MPOD and
SEM in (d.u.)

Average %
change in
Younger group

Average % change in
Older group

MPOD

MPOD

SEM

MPOD

SEM

SEM

Young

Old

Young

Old

Lutein

0.053

0.042

0.017

0.019

14.94

5.37

7.98

3.49

“Micro”

0.070

0.026

0.017

0.014

26.74

3.99

4.48

0.81

Table7.7.5 Overall response to the supplementation across the age groups.

Section 7.8
Discussion
A change in the level of MP was observed for all the subjects who participated in
the study. To test if such changes observed were significant or not, a two tailed
Student’s t-test was conducted. A 0.05 confidence level was used to infer if
changes in the MPOD values were significant or not. The subjects who were
found to have significant change in MPOD taking the lutein supplement are given
in the table 7.8.1 below.
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Subject Code
L1
L2
L3
L4
L5
L6
L8
L9
L10
L12
L13
L18
L19
L21
L22
L23
L24

Supplement

Gender

Age
Group

Increase/Decrease

Lutein
Lutein
Lutein
Lutein
Lutein
Lutein
Lutein
Lutein
Lutein
Lutein
Lutein
Lutein
Lutein
Lutein
Lutein
Lutein
Lutein

Male
Female
Male
Male
Male
Female
Female
Male
Male
Female
Female
Male
Male
Female
Male
Female
Female

Young
Young
Young
Young
Young
Young
Young
Young
Young
Young
Old
Old
Old
Old
Old
Old
Old

Increase
Decrease
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase
Decrease
Increase

Table 7.8.1 Subjects on the Lutein supplement with significant change in their
MPOD levels at the end of the study.
Similarly subjects who were on the “Micro” supplements and had shown a
significant change in their MPOD levels are given in table 7.8.2.
Subject Code

Supplement

Gender

Age
Group

Increase/Decrease

M1
M3
M4
M5
M6
M7
M13
M14

Micro
Micro
Micro
Micro
Micro
Micro
Micro
Micro

Female
Male
Female
Female
Female
Female
Male
Female

Young
Young
Young
Young
Young
Young
Old
Old

Increase
Increase
Increase
Increase
Increase
Increase
Increase
Increase

Table 7.8.2 Subjects on the “Micro” supplement with significant change in their
MPOD levels at the end of the study.
The subjects that did not show significant changes in their MPOD at the 0.05
confidence level consuming either of the supplements are given in table 7.8.3.
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Subject Code

Supplement

Gender

Age Group

Increase/Decrease

L11
L15
L16
L17
L20
M2
M15

Lutein
Lutein
Lutein
Lutein
Lutein
Micro
Micro

Female
Male
Male
Male
Male
Female
Male

Young
Old
Old
Old
Old
Young
Old

Increase
Decrease
Increase
Increase
Increase
Decrease
Decrease

Table 7.8.3 List of subjects whose MPOD levels was not changed significantly at
the end of the study.

On inspection of tables 7.8.1 and 7.8.2, we observe that more individuals in the
younger age group have shown significant changes in their MPOD levels than
individuals in the older age group.
The slope of the regression line obtained for the plot of average weighted MPOD
values with respect to the week number was analyzed by performing a t-test to
determine whether it was significantly different from zero. A 0.05 confidence
level was set to test for significance. The subjects on the lutein supplement
grouped in table 7.8.1 that had shown a significant difference between their
MPOD values at the start and end of the study were tested to determine if their
rate of change of MPOD was significantly different from zero. These are listed in
table 7.8.4. In table 7.8.5 we listed the subjects from table 7.8.2 who had shown a
significant change in their MPOD and were on the “Micro” supplement.
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Subject

Supplement

Gender

Age Group

L2

Lutein

Female

Young

L3

Lutein

Male

Young

L4

Lutein

Male

Young

L5

Lutein

Male

Young

L21

Lutein

Female

Old

L22

Lutein

Male

Old

Table 7.8.4 Subjects on Lutein supplement who had shown an overall significant
change and a significant rate of change in their MPODs

Subject

Supplement

Gender

Age Group

M1

Micro

Female

Young

M5

Micro

Female

Young

M6

Micro

Female

Young

M7

Micro

Female

Young

Table 7.8.5 Subjects on the “Micro” supplement who had shown an overall
significant change and a significant rate of change in their MPODs

We observe from table 7.8.4 that for the lutein supplement, more subjects in the
younger age group had shown a significant rate of change in their MPOD values.
The significant rate of change amongst younger subjects is only observed in table
7.8.5 with the “micro” supplement.
Referring to table 7.7.5 we observe that average percentage increase in MPOD for
subjects on lutein has been almost the double the value for the younger
individuals compared to that observed among the older individuals. For the
“Micro” supplement, the overall percentage change in the MPOD values is seen
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to be even more pronounced compared to what we observe in the lutein group. A
factor that might stand out as pertinent in observing such a trend might be based
on the baseline or the pre-supplemental values of MPOD measured. This
proposition was pointed out in Bone et al.17 The baseline values in the older age
group are observed to be comparatively higher than the baseline values in the
younger age group. If the value of saturation of lutein and zeaxanthin in the retina
had already been reached in the individuals as indicated by a higher baseline
value, a slower rate of change in the MPOD values can be expected due to
supplementation. Hence apparently the younger group had a better response to the
supplementation than the older group with both formulations. Further, the average
baseline values of the MPOD of the younger subjects are lower in the “Micro”
group than the lutein group, which again might be an indicator that higher levels
of rise might be expected amongst the younger subjects in the “Micro” group than
the younger subjects in the lutein group as seen in table 7.7.5.
In table 7.8.4 we observe that both males and females on the lutein supplement
have shown significant rates of changes in their MPOD. Following table 7.8.5, we
observe that only females in the younger age group taking the “Micro”
supplement have shown a significant rate of change in their MPOD. However,
due to the limited amount of data, we cannot pursue a gender-based analysis of
the responses in each age group.
We have observed that out of 32 subjects who participated, 25 showed a
significant overall change in their MPOD levels. Out of the 25 subjects, 10
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individuals have clearly shown a significant rate of change in their MPOD level
during the study. As changes in MPOD levels could be monitored and measured
with Mapcatsf, it could be considered a choice of clinical practitioners for use in
similar such supplement studies.
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8. Chapter 8
Protective Role of Lutein found in the Lens of the Human Eye.
Section 8.1
Introduction:
The lens in the eye is crystalline in nature and composed of water soluble
proteins118. The components of the lens undergo structural changes leading to
changes in opacity levels which at advanced stages renders the lens, or the
pertinent region of the lens, cataractous76. Cataract is one of the leading causes of
vision impairment in the world especially amongst the elderly.77
Refraction119 and transmittance120 of light by the lens are the two major factors
affecting the quality of the image formed on the retina. Therefore for maintenance
of good visual performance, transparency of the lens is of major importance.
The overall optical density of the lens changes with age47 ,with the nuclear121 and
the cortical121 regions being

the primary areas showing age-related opacity

changes. However,opacity developed in the posterior subcapsular region is not
age-related79 but due to reasons such as steroid intake122, diabetes123 and exposure
to ionizing radiation124.
Though there are various factors associated with the three types of cataracts
mentioned in chapter 6, the lens being subjected to oxidative stress is a common
factor responsible for the occurrence of cortical and nuclear cataracts.125
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Oxidative stresses are due to UV light exposure,126 oxidants in the ocular fluids,127
and endogenous oxidants which are produced in the lens.128 Traces of lutein and
zeaxanthin have been reported to be found in the human lens.

129,64

A protective

role of the carotenoids lutein and zeaxanthin from oxidative stress is also believed
to be associated with them acting in protective capacity for lipids found in the
lens which are susceptible to attack by free oxygen radicals.130
As stated in chapter 1, lutein and zeaxanthin have their major presence as the
constituents of MP in the primate retina. Levels of lutein and zeaxanthin in the
blood are indicative of the MPOD.131 The lens indirectly derives its nutrients from
blood132 via the aqueous humor. Therefore MPOD might be expected to be
correlated with levels of lutein and zeaxanthin in the lens.
Our prime goal in this study was to investigate the existence of a relationship as
proposed in Hammond et al 1997, where the variation of the lens optical density
with MPOD was studied and a negative trend was reported between the two
quantities. Such a study is of great interest since lutein and zeaxanthin are the
only two carotenoids that have been identified in the lens, and a diet rich in lutein
and zeaxanthin has been shown to be a factor in preventing development of
cataracts.133
Our tests were conducted using Mapcatsf for determining both the MPOD and the
lens optical density.
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Section 8.2
Methods:
Subject Recruitment:
A total of 89 subjects were recruited in the age range of 18 to 80 years with an
average age ± SD of 34 ± 15 years. The subjects recruited were in good visual
health, and were non-smokers. All the subjects signed an informed consent form
approved by FIU-IRB prior to testing. Since there have been reports of high levels
of concordance of both the MPOD134 and the lens densities 56between both the
eyes, only the right eye was tested.
Section 8.3
MPOD and LOD measurement:
A detailed description of Mapcatsf and the testing procedure for both the MPOD
and LOD is included in chapter 2.
Section 8.4
Results
The total recruitment of subjects was divided into three age groups: young (18 to
30 years), middle aged (30 to 50 years) and old (50 to 80 years). The data for each
age group were further classified based on gender as given in table 8.1. In tables
8.2 and 8.3 the average MPOD and the lens density values were calculated
separately for males and females in each age group.
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Age 18 to 30 years

Age 30 to 50 years

Age 50 to 80 years

Gender

No.

Mean
Age(yrs.)

S.D.
(yrs.)

No.

Mean Age
(yrs.)

S.D.
(yrs.)

No.

Mean
Age(yrs.)

S.D.
(yrs.)

Males

27

23.5

3.06

10

35.5

4.30

13

58

6.37

Females

23

22.86

2.73

5

37

5.52

11

58.6

7.18

Table 8.1 Age- and gender-based classification of the participating subjects.

Gender

Age 18 to 30 years

Age 30 to 50 years

Age 50 to 80 years

Mean
test
values

Mean
retest
values

Mean
test,
retest

Mean
test
values

Mean
retest
values

Mean
test,
retest

Mean
test
values

Mean
retest
values

Mean
test,
retest

Male

0.445

0.432

0.438

0.471

0.468

0.469

0.556

0.564

0.560

Female

0.406

0.407

0.407

0.566

0.556

0.561

0.438

0.429

0.433

Table 8.2 Average of MPOD obtained from test retest for the subjects.
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Gender

Age 18 to 30 years

Age 30 to 50 years

Age 50 to 80 years

Mean
test
values

Mean
retest
values

Mean
test,
retest

Mean
test

Mean
retest
values

Mean
test,
retest

Mean
test

Mean
retest

Mean
test,
retest

Male

0.549

0.562

0.555

0.620

0.642

0.631

0.891

0.900

0.895

Female

0.498

0.513

0.505
5

0.635

0.659

0.647

0.936

0.951

0.944

Table 8.3 Average of LOD obtained from test retest for the subjects.

A scatter plot shown in Fig. 8.1 followed by a regression analysis was pursued in
order to investigate the overall trend of the variation of LOD with MPOD for all
the age groups combined.

Lens Optical Density

1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0

0.2

0.4
0.6
MPOD

0.8

1.0

Fig. 8.1 Scatter plot of LOD with MPOD for all subjects. The regression line
shown in red is given by the Eq.: y=0.528+0.267x, with a p<0.0175.
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On regression analysis of the scatter plot in Fig. 8.1, we obtained a positive slope.
The slope and the intercept were 0.267 and 0.528 respectively. The r2 value
obtained was 0.0598 with p< 0.0175, indicating a very low level of correlation
between LOD and MPOD.
To observe the effect in each age group of the variation of LOD with MPOD, we
plotted the data for each age group as shown in Fig. 8.2.

1.4

18 to 30 years.

Lens Optical Density

1.2

30 to 50 years.
50 to 80 years

1.0

0.8

0.6

0.4

0.2
0.0

0.2

0.4

0.6

0.8

1.0

MPOD

Fig. 8.2 Regression lines for the scatter plots of LOD with MPOD for the three
age groups. For the group of subjects between 18 and 30 years the Eq. of the line
was y=0.514+0.056x (shown in red), p value=0.3863; For the group of subjects
between 30 and 50 years the Eq. of the regression line was y=0.469+0.341x
(shown in blue), p value =0.0867; and the Eq. of the regression line for the group
of subjects between 50 and 80 years was y=0.866+0.107x(shown in green), pvalue=0.625
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Further, we investigated whether there was a difference between males and
females in the separate age groups regarding the relation of MPOD to LOD . The
results are shown in Figs 8.3 and 8.4.

1.2

Lens Density

1.0

18 to 30 years.
30 to 50 years.

0.8

50 to 80 years

0.6
0.4
0.2
0.0

0.2

0.4

0.6

0.8

1.0

MPOD

Fig. 8.3 Regression lines for scatter plots of LOD with MPOD for females in the
three age groups. For the age group of females between 18 and 30 years the
regression line has an Eq.: y=0.494+0.028x (shown in red), p value =0.784.For
the age group of females between 30 and 50 years the regression line has an Eq.
y=0.775 – 0.228x (shown in blue), p-value=0.507. For females in the age group of
50 to 80 years the regression line: y= 0.836+0.312x (shown in green), pvalue=0.312.
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1.4

Lens Density

1.2

18 to 30 years.
30 to 50 years.

1.0

50 to 80 years

0.8
0.6
0.4
0.2
0.0

0.2

0.4

0.6

0.8

1.0

MPOD

Fig. 8.4 Regression lines for scatter plots of LOD with MPOD for males in the
three age groups. For the age group of males between 18 and 30 years the
regression line has an Eq.: y=0.551+0.009x (shown in red), p-value=0.895. For
the age group of males between 30 and 50 years the regression line has an Eq.
y=0.432 + 0.423x (shown in blue), p-value =0.0914. For males in the age group of
50 to 80 years the regression line: y= 0.885+0.019x (shown in green), p
value=0.962.

Section 8.5
Discussion:
The regression line in Fig. 8.1 has a positive slope. Such a trend was also reported
by Hammond et al. 1997.18 When analysis was pursued on the scatter plots for
each age group separately (shown in Fig. 8.2), the regression lines had positive
slopes, albeit very small except for the 30 to 50 age group. Such a trend
contradicts the relationship indicated in Fig. 2 of Hammond et al 1997 for the age
groups considered “middle aged” and “oldest” where they had reported a decline
in LOD with the increase in MPOD of the subjects. However, the upper and lower
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ages of the subjects in the middle and the older age groups in our study were
different than those in Hammond et al. 1997.

In the study conducted by

Hammond et al, their middle age group involved individuals between 48 and 66
years of age, and the older age group involved subjects between 67 and 82 years
of age. In our study the middle age group consisted of individuals between 30 and
50 years and the older age group comprised of individuals between 50 and 80
years. The variation in the upper and lower age limits in both the studies prevents
a direct comparison of the data obtained from the two studies. As LOD increases
with the subject’s age, it might be that older subjects were more conscious about
their diet, resulting in the consumption of carotenoid-rich foods such as spinach135
and kale 136 and higher levels of lutein and zeaxanthin in the blood serum and the
fovea. Based on this hypothesis, a positive correlation between lens density (a
surrogate of biological age) and MPOD (a surrogate of lens carotenoids) might be
expected. However such a proposition cannot be well supported without
conducting an experiment on subjects with their dietary habits taken into
consideration. Similarly, aside from dietary habits, lifestyle, especially a measure
of the amount of exposure to UV radiation of the subjects, should also be
considered.137,

83

Also an

important step towards further improving LOD

measurement would be not to involve photopic responses whereby measurements
could be affected by the variation of the L and M cones in the retina. 56
From an overall standpoint, both the LOD and MPOD measured depend on
various factors such as dietary habits and UV exposure. Therefore when subjects
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are recruited, care should be taken to include these factors for the purpose of
having better understanding of the overall statistical outcomes.
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9. Chapter 9
Role of Involuntary Eye Movements in Designing an Optimum Gaze
Facilitating Stimulus
Section 9.1
Introduction
Though the MP is normally considered to have its peak concentration in the
center of the fovea,2 there are published research findings that reveal a variability
in the concentration around the region of the fovea for some individuals.
138,139,140

Such findings have led researchers to ask the question: when MPOD is

measured by HFP by imaging a stimulus around the foveal region of the retina,
how the measured value can be interpreted taking into account the variability of
an individual’s MP distribution? Though as a naïve approach one can consider the
value obtained is an overall average of the distribution, there have been results
from studies that have been accepted which claim that MPOD measured by HFP
is actually the value at a location in the retina associated with the edge of the
image formed by the foveal stimulus.66,33,141 However Bone, Landrum, and Gibert
in 200448 published an article which contradicted this hypothesis. In their study
they modified an HFP instrument by using annular stimuli of different diameters
up to 1.5º (the diameter of the foveal stimulus originally used). Such an alteration
helped them determine the average MPOD at various eccentricities. Similar
testing and analysis was conducted by comparing a 1º diameter foveal stimulus
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with an annular stimulus of the same diameter. For both the 1º and 1.5º stimuli,
the average MPOD value was less than that of the corresponding annular
stimulus. Such observations led them to interpret the proposition of an edge effect
in MPOD measurement to be an artifact of fixational eye movements.
These eye movements can be classified into three types which are tremor,
microsaccades and drift.49 Microsaccades are generally associated with peripheral
vision. Drift movements are believed to have a compensatory role in maintenance
of gaze13 and therefore are associated with foveal vision142 and have amplitudes of
the order of 0.36º.50 Such orders of magnitude of the drift movements can lead to
alteration of the area of the retina sampled during MPOD measurements. If the
flicker null/minimum settings are made during the course of such movements, it is
quite likely that the measured value of MPOD might be closer to the value at the
edge of the stimulus.
An experiment was therefore conducted to test whether the cross-hairs used with
the Mapcatsf stimuli represented the optimum design for accurate fixation, or
whether alternative designs might lead to improved fixation.
Section 9.2
Experimental Setup
Three types of central gaze facilitating foveal stimuli were designed as shown in
Fig. 9.1.
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.

Fig.9.1The types of configurations of foveal stimuli tested for facilitating
minimum fixational eye movements.
The experimental setup consisted of a projector, a screen, and a chair as shown in
Fig 9.2. The chair had a head mount and a chin rest attached. It was used to ensure
that the subject was in a head-fixed position at a fixed distance from the screen.
This setup was used so that the projected stimulus subtended exactly 1.5º diameter
for the participating subject, the same as the size of the foveal stimulus in
MapcatsfTM.

117

Sony® Topcon
projector
Screen

Chin rest

Head mount

73.5 inches

.

Chair with armrest

Projector stand

Fig. 9. 2 The screen and projector setup
To record the eye movements associated with fixation, the primary instrument
used for the study was a commercial software-controlled eye tracker, “Viewpoint
PC-60”, manufactured by Arrington Research Systems, Scottsdale Arizona USA.
The eye tracker was designed for tracking monocular gaze only for the left eye. It
comprised a CCD camera of 360 by 240 pixels resolution that captured the scene
at 30 frames per second. An infrared camera tracked the center of the pupil which
was illuminated by an infrared LED while the subject gazed at the stimulus. The
scene camera, eye tracking infrared camera and infrared LED were assembled on
an eyewear frame which could be worn by the subject. The eyewear setup for the
eye tracker is shown in Fig.3.

118

Scene camera

Infrared eye
camera
Eyewear frame

Infrared
light source

Fig. 9.3 The hardware components of the eyetracker
The window corresponding to the tracking software is shown in the Fig 9.4. An
Excel file recorded the x and y coordinates with respect to the scene as captured
in an “.avi” file.
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Scene as captured by the scene camera

Pupil cursor

Gaze position

Calibration grid

Fig. 9.4 The controlling window for the eyetracker.143
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Section 9.3
Experiment
Ten subjects with no vision anomalies were recruited and signed an informed
consent approved by the FIU-IRB. Each subject was required to participate three
times aside from one subject who was only able to participate twice. Prior to the
start of the experiment, the subjects had their right, non-tracking eye occluded
with an eyepatch. This was done for two reasons. The primary reason was that
Mapcatsf measures MPOD of one eye at a time and the other reason was,
according to feedback from subjects, while getting tested on Mapcatsf, the
availability of the non-testing eye for vision made gaze fixation of the testing eye
difficult. The subject was then guided to put on the eyetracker as shown in Fig
9.3. Once a proper alignment of the eyewear was obtained, the pupil cursor was
locked within the region of interest to avoid unnecessary shifts.
With the eye camera being properly aligned to ensure optimum tracking, the
subjects were seated with their chin on the chin rest and their head restrained with
a forehead rest. The operator subsequently adjusted the alignment of the scene
camera on the eyewear to fit the entire screen in the field of the scene camera as
shown in the Gaze Space window of Fig.9.4.. A head-fixed calibration was then
conducted so that, when mapped, the gaze coordinates would be well correlated to
the movie frames captured by the scene camera.
The calibration was carried out by the operator by pointing a laser pointer at the
desired point on the screen as monitored on the Gaze Space of the tracking
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software. Once the subject’s gaze was precisely located at the desired point on the
scene, the calibration point was recorded on the Eye Space of the window of the
tracking software by the operator. This was repeated 15 more times until the
points were well spread and when joined by straight

lines appeared

approximately as a rectangular grid. A well calibrated grid is shown in Fig. 9.4.
To correct for any consistent offset between the line of sight of the scene camera
and the eye, a slip correction was done. The slip correction was carried out by
selecting a point in the Eye Space window and the operator directing the subject
to look at the laser pointer pointed at the corresponding point on the screen. The
operator subsequently clicked the “Slip-Correction” button on the Eye-Space.
Once a proper alignment, calibration and slip correction were obtained, the
subject was presented sequentially with the three stimuli shown in Fig 9.1. For
each presentation of a stimulus, the subject was directed to fixate his/her gaze at
the center of the stimulus for 60 seconds duration. During these 60 seconds, both
the scene and the corresponding gaze parameters, including the x and y coordinates and velocities of various eye movements, were recorded in “.avi” and
“.xls” files respectively. Three repeat measurements were done with each subject
on different days, aside for the case of one subject, who could only participate
twice.
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Section 9.4
Data Analysis
The goal of the experiment was to determine if a central gaze fixating stimulus
can be designed for Mapcatsf, which involves least variation of gaze position due
to fixational eye movements. With the assumption that amplitudes of the
fixational eye movements associated with foveal vision are the same in all
directions, the fixation points were assumed to lie within a region which would be
defined by a circle with the average of the recorded gaze coordinates as the center
of the circle. The distance of the gaze positions with respect to the average of the
fixation coordinates taken as the reference point was computed by using Eq. 1 as
shown below.

( x − xaverage )2 + ( y − yaverage )2 = r 2 ……(1)
The gaze positions as recorded by the software have normalized values between 0
and 1 for both the horizontal and vertical directions, as shown below in Fig 9.5.
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(0,0)

(1,0)

(1,1)

(0,1)

Fig. 9.5 Format of the scene as recorded
However on actual measurement, the extremities of the screen which are also the
extremities of the field of view of the scene camera in the x and y directions were
49 inches and 40 inches respectively. Therefore the x and y coordinates recorded
were multiplied by 49 and 40 respectively and were termed as converted x and y
coordinates respectively. If any of the converted gaze coordinates were found far
away from the average of the distribution, the entire frame associated with the
coordinate was rejected. Such outliers in data are believed to be associated with
blinks or saccades.
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Fig 9.6 A sample of Transformed gaze coordinates in the Y direction prior to
analysis.
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Fig 9.7 A sample of Transformed gaze coordinates in the X direction prior to
analysis.
Since the eccentricities with respect to the visual axis are given in terms of angles,
each fixation point was converted to angular eccentricities by the Eq.2:
 r 

 73.5 

θ = tan −1 
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………………….. (2)

The number in the denominator of Eq. 2 is the distance in inches from the headmount to the screen.
The standard deviation in θ was interpreted as a measure of the variation in gaze
position. A comparative analysis was done to statistically confirm the type of
central gaze facilitating stimulus which resulted in the minimum variation of the
gaze. A repeat measurement analysis of variance (ANOVA) was performed using
the SPSSTM software. The results are summarized in table 9.1.
Expt.
No.

No. of
Readings

Type of
Stimulus

Minimum
Variation
in gaze
(º)

Maximum
Variation
in gaze (º)

Mean
Variation
in gaze (º)

Standard
Deviation in
gaze(º)

1

29

Vertical
Cross

0.16

0.58

0.35

0.11

2

29

Dot

0.14

0.72

0.35

0.14

3

29

X-cross

0.17

0.67

0.37

0.13

Table 9.1 Variation in gaze for the three types of stimuli tested.

The column “No. of readings” in table 9.1 implies the total of the three sittings for
9 subjects and the 2 sittings for the subject who could not participate for the third
sitting. An F-test was further carried out to gain an understanding of the
comparative variation in the gaze for the three types of stimuli tested among the
subjects. The F-value144 is defined by Eq. (3).

F=

between-group variability
……………. (3)
within group variability
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In Eq. 3 there are 2 degrees of freedom associated with the numerator and 3times
(No. of readings-1) degrees of freedom associated with the denominator. From a
look up table, the critical F-value was 3.11 for the p-value to be < 0.05. The Fvalue for our data set was 0.617 calculated from the SPSSTM software and gave a
p-value of 0.543 which is statistically insignificant.
Section 9.5
Discussion and Conclusion
Since The F-value we obtained using the SPSSTM software was less than the
critical F-value, there is no significant difference between the level of influence
that fixational eye movements might have on facilitating central gaze fixation for
the three types of stimuli. From a statistical standpoint, selecting a particular type
of central gaze fixating stimulus cannot significantly reduce fixational eye
movements. Hence we surmise that though developers of HFP instruments might
be tempted to consider an optimum gaze fixating stimulus, results of our
experiment show that it might not be an effective way to reduce the effects of
fixational eye movements on MPOD measurement.
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10. Chapter 10
Conclusion
Measuring and monitoring MP and the lens optical density for research and
clinical purposes is the intended area where we would desire Mapcatsf, the novel
LED-based HFP instrument to be used. The preliminary test-retest results of
Mapcatsf for MPOD and LOD measurements as discussed in chapter 3 showed
high levels of repeatability. This prompted us to further pursue the various testing
and analyses as described in the later chapters of the dissertation.
In chapter 4 we observed that if changing either of the component LEDs is
necessary, for maintenance of precise standards of measurement it is better to
reprogram the microprocessor taking into account the spectrum of the replaced
LEDs. Mapcatsf incorporates the age-related change in the luminous efficiency
function. The outcome of chapter 5 is directed towards researchers who have
reported an age-related decline in MPOD values measured by HFP. For the sake
of improving the precision of their results, they are advised to consider the
importance of incorporating the changing levels of the luminous efficiency
function with age in their instruments which otherwise might lead to erroneous
outcomes.
The true novel aspect of Mapcatsf being its capacity to measure LOD is further
established when, in chapter 6, results are compared for the same group of
subjects having their lens densities measured at absolute scotopic thresholds. A
good level of agreement obtained between the results of the LOD interpreted in
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terms of LEA under the two separate viewing conditions further established the
novel feature of Mapcatsf of being capable of measuring the LOD.
As supplementation studies to raise the levels of MP represent a growing trend
among researchers, the capability of Mapcatsf to monitor changing levels of
MPOD in individuals was tested and established as described in chapter 7.
MPOD measured by HFP has been reported to represent the value at the edge of
the foveal stimulus used. As described in chapter 9, this observation was
attributed to fixational eye movements. Involvement of fixational eye movements
with measured values of MPOD prompted us to test for an optimum gaze fixating
stimulus which could be incorporated in Mapcasf. An eye tracking experiment
pursued with 10 subjects led us to the inference that the current Mapcat stimulus
is essentially optimized.
The overall outcome of the study establishes the credibility of Mapcatsf as a
research grade instrument in labs and clinical settings. Further, if a future study is
conducted where the same subject’s MPOD is measured both by Mapcatsf and by
one of the other such similar instrument available commercially, results from such
a study would enable Mapcatsf to further stand out amongst its competitors.
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